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Beta-amyloid precursor protein cleavaging enzyme 1 (BACE1), a major neuronal β-
secretase critical for the formation of β-amyloid (Aβ) peptide, is thought to be one of 
the key therapeutic targets that can prevent the progression of Alzheimer’s disease 
(AD). Although complete ablation of BACE1 gene prevents Aβ formation, I found 
that at the mossy fiber projections in CA3 area of hippocampus, where BACE1 is 
highly expressed in normal brain, BACE1 knockout (KO) mice display reduced 
presynaptic function, as measured by an increase in paired-pulse facilitation ratio, and 
abolished mossy fiber LTP, which is very likely due to presynaptic Ca2+ signaling 
abnormality.  
In order to determine the function of BACE1 in an intact CA3 circuit, whole-cell 
recordings were performed from pyramidal cells and inhibitory interneurons in the 
CA3 area that receive mossy fiber inputs. My analyses revealed a decrease in 
presynaptic release at mossy fiber synapses onto CA3 pyramidal cells of BACE1 KO 
  
mice as determined by a significantly reduction in the frequency of miniature 
excitatory postsynaptic currents (mEPSCs) and enhanced paired-pulse facilitation 
ratio. In contrast, BACE1 KO mice do not exhibit significant dysfunction at mossy 
fiber input on CA3 inhibitory interneurons. However, presynaptic function at 
inhibitory input on CA3 pyramidal neurons is impaired in BACE1 KOs, as seen from 
a reduction in paired-pulse depression of inhibitory postsynaptic responses and a 
significant decrease in the frequency of miniature inhibitory postsynaptic currents 
(mIPSCs). 
Finally, to restore the deficits caused by BACE1 inhibition, I demonstrated that brief 
application of nicotine can improve presynaptic release and recover mossy fiber LTP 
in BACE1 KOs by activating α7-nAChRs, which recruits Ca2+ induced Ca2+ release 
to rescue the abnormal presynaptic Ca2+ signaling. 
 
In summary, my studies suggest that BACE1 may play a critical role in regulating 
presynaptic function, especially activity-dependent strengthening of presynaptic 
release. The presynaptic dysfunction seen in BACE1 KOs is likely specified by the 
postsynaptic target, the CA3 pyramidal neurons, independent of the type of inputs. 
And nicotine or α7-nAChR agonists may be a potential pharmacological means to 
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Chapter 1: Introduction 
 
Section 1 Alzheimer’s disease and synaptic alteration 
Subsection 1 What is Alzheimer’s disease? 
First described by German psychiatrist and neuropathologist Alois Alzheimer 
in 1906, Alzheimer’s disease (AD) has been recognized as one of the most common 
form of senile dementia around the world. AD is clinically characterized by a global 
decline of cognitive function including memory loss (Citron, 2004a). Although it has 
been studied for 100 years, there is still no effective disease-modifying treatment 
currently available for AD. It has been found that extracellular amyloid plaques 
consisting predominantly of amyloid beta 42 (Aβ42), and intraneuronal tangles 
consisting of an aggregated form of the neuronal protein tau, are the two pathological 
hallmarks of AD (Citron, 2004a). Current theories implicate the production of Aβ as a 
key molecular event (Hardy and Selkoe, 2002), that initiates synaptic dysfunction, 
which may be the basis for memory loss in early stages of the disease (Walsh and 
Selkoe, 2004a; Shankar and Walsh, 2009), ultimately, disease progression leads to 
severe neurodegeneration and memory loss. Aβ is produced from sequential 
proteolytic cleavage of amyloid precursor protein (APP) by two endoproteolytic 
enzymes, β- and γ-secretase (Fig. 1.1). Consequently, inhibiting the activity of these 
enzymes has surfaced as one of the major disease-modifying approaches for AD 
(Citron, 2004a). Recently, it has been found that γ-secretase cleaves other important 




(Sisodia and St George-Hyslop, 2002; Selkoe and Kopan, 2003). Therefore, inhibiting 
β-secretase is now receiving renewed attention (Vassar, 2002; Citron, 2004a, b). In 
order to develop effective therapeutics, a detailed molecular and cellular 
understanding of the role of β-secretase in synaptic function is necessary. In addition, 
accumulating evidence suggests that the initial pathology of AD is a result of synaptic 
dysfunction (Walsh and Selkoe, 2004b; Shankar and Walsh, 2009). Therefore, in my 
thesis, I focused on the consequences of inhibiting BACE1, identified as the major 
neuronal β-secretase (Hussain et al., 1999; Sinha et al., 1999; Vassar et al., 1999; Yan 
et al., 1999), at synaptic function and plasticity level, I tried to identify the synapses 
affected by losing BACE1 activity and the underlying mechanisms of the deficits in 
CA3 area of hippocampus, where the expression of BACE1 is most prominent in 
normal brain (Laird et al., 2005; Zhao et al., 2007). These findings will aid in the 
development of effective therapeutics that can overcome the negative effects of long-
term BACE1 inhibition needed for AD treatment. First of all, I will briefly introduce 
the topic and current understanding of synaptic plasticity in the following two 









Figure 1.1. A diagram of amyloid precursor protein (APP) processing 
pathways. 
The transmembrane protein APP (membrane indicated in blue) can be cleaved by 
two pathways, the non-amyloidogenic α-secretase pathway and the amyloidogenic 
β-secretase pathway. In the non-amyloidogenic pathway, α-secretase cleaves in the 
middle of the β-amyloid (Aβ) region (black) to release soluble APP-fragment 
sAPP-α. The APP C-terminal fragment 83 (APP-CTF83) is then cleaved by γ-
secretase to release APP intracellular domain (AICD) and P3 fragment. In the 
amyloidogenic pathway, β-secretase cleaves APP and produces soluble fragment 
sAPP-β. The APP-CTF99 is then cleaved by γ-secretase to form Aβ40, Aβ42 and 
AICD. 
 
Subsection 2 Synaptic plasticity and memory formation 
It is widely believed that long-term changes in the strength of synaptic 
transmission underlie the formation of memories. Hebb is often recognized as the first 
person to crystallize this idea by proposing that coincident activity of pre- and 
postsynaptic neurons strengthens synaptic connections (Hebb, 1949). It was 




decrease the strength of synaptic transmission between them (Stent, 1973). It has been 
demonstrated experimentally that high frequency stimulation, which can lead to 
correlated activity in pre- and postsynaptic cells, can indeed strengthen synapses 
(Bliss and Lomo, 1973). On the other hand, a prolonged low frequency stimulation of 
afferents, which would lead to presynaptic activation in the absence of correlated 
postsynaptic activity, produces a long-term decrease in synaptic transmission (Dudek 
and Bear, 1992; Mulkey and Malenka, 1992). The strengthening of synaptic 
connections is termed long-term potentiation (LTP), while the weakening of synaptic 
transmission is called long-term depression (LTD). Since their initial discovery, both 
LTP and LTD have been found to occur in a diverse set of synapses across many 
different brain areas (reviewed in (Malenka and Bear, 2004)). These long lasting 
forms of synaptic plasticity share similar mechanisms of induction, expression, and 
maintenance with those of long-term consolidation of several forms of memory 
(Lisman, 1989; Bailey et al., 1996; Bear, 1996; Martin et al., 2000; Paulsen and 
Sejnowski, 2000; Bliss et al., 2003; Lynch, 2004; Barco et al., 2006; Morris, 2006). 
Moreover, long-term alterations in synaptic transmission, similar to characteristics of 
LTP and LTD, have been observed in vivo during various learning paradigms (Rioult-
Pedotti et al., 1998; Rodrigues et al., 2004; Schafe et al., 2005; Stefan et al., 2006; 
Whitlock et al., 2006), which further suggests that LTP and LTD may be cellular 
substrates for memory formation. 
While LTP and LTD are effective models for mediating synapse-specific 
changes required for memory formation, theoretical considerations indicate that 




plasticity mechanisms that operate at a slower time scale (hours to days) (Bienenstock 
et al., 1982; Bear et al., 1987; Abraham and Bear, 1996; Turrigiano et al., 1998; 
Turrigiano and Nelson, 2004). For example, without homeostatic regulation, the 
increase in postsynaptic activity after LTP might result in a vicious cycle of 
potentiation that not only degrades the capacity of neural circuits to store specific 
information, but could also culminate in a run-away excitation of the neural network. 
There are several mechanisms of homeostasis that can stabilize the nervous system: 
adjusting excitatory synaptic transmission postsynaptically (Bienenstock et al., 1982; 
Bear et al., 1987; Turrigiano et al., 1998; Abbott and Nelson, 2000; Turrigiano and 
Nelson, 2004), modulating the excitability of neurons (Desai et al., 1999; Aizenman 
et al., 2003; Maffei et al., 2004), changing inhibitory circuits (Kilman et al., 2002; 
Morales et al., 2002; Maffei et al., 2004; Maffei et al., 2006), and altering presynaptic 
function (Burrone et al., 2002; Thiagarajan et al., 2002; Thiagarajan et al., 2005). 
While most studies of synaptic plasticity related to memory formation focus on LTP 
and LTD, it is prudent to understand that alterations in homeostatic plasticity can also 
affect learning and memory. 
Subsection 3 Molecular mechanisms of synaptic plasticity 
While LTP and LTD have been observed in many different brain areas, the 
majority of knowledge about their molecular mechanisms comes from studies in the 
hippocampus. This is partly because the hippocampus is an area of the brain that is 
critically involved in the formation of long-term memories (reviewed in (Lynch, 




pathology in most AD brains (reviewed in (Walsh and Selkoe, 2004b)). Therefore, I 
will briefly review the mechanisms of synaptic plasticity in the hippocampus. 
In the hippocampus, two major forms of LTP and LTD are observed: one that 
is dependent on NMDA receptor (NMDAR) activation and another that is 
independent of NMDARs (Nicoll and Malenka, 1995; Lynch, 2004). The most widely 
studied forms of LTP and LTD are those dependent on NMDARs in the CA1 region; 
hence, their mechanisms have been fairly well characterized. NMDARs, due to 
activity-dependent relief of their Mg2+ block (Malenka and Nicoll, 1999), act as 
coincident detectors for pre- and postsynaptic activity. In addition, activation of 
NMDARs allows influx of Ca2+ (Connor et al., 1999; Yuste et al., 1999; Kovalchuk et 
al., 2000), which can act as a second messenger to activate various downstream 
effectors in the postsynaptic neuron. It is thought that both the magnitude and 
temporal pattern of Ca2+ increase determines the expression of either LTP or LTD, by 
differentially regulating the activity of protein kinases and phosphatases (Lisman, 
1989). One of the key downstream events of LTP and LTD is regulation of synaptic 
AMPA receptors (AMPARs) (for review see (Malinow and Malenka, 2002; Lee, 
2006)). AMPARs are the major mediators of fast excitatory synaptic transmission in 
the central nervous system (CNS), therefore their function directly dictates synaptic 
strength. Several studies demonstrated that LTP increases synaptic content of 
AMPARs, predominantly by an activity-dependent insertion of receptors containing 
the GluA1 subunit (GluR1) (Shi et al., 1999; Hayashi et al., 2000; Shi et al., 2001). 
This requires concomitant activation of Ca2+/calmodulin-dependent protein kinase II 




(Boehm et al., 2006) and serine 845 (S845) (Esteban et al., 2003) or serine 831 (S831) 
(Esteban et al., 2003; Lee et al., 2010). GluA1-S818 is a protein kinase C (PKC) 
phosphorylation site (Boehm et al., 2006), while GluA1-S845 is a protein kinase A 
(PKA) phosphorylation site (Roche et al., 1996), and GluA1-S831 can be 
phosphorylated by both PKC (Roche et al., 1996) and CaMKII (Barria et al., 1997; 
Mammen et al., 1997). Many studies confirm that CaMKII, PKC, and PKA are 
involved in NMDAR-dependent LTP (reviewed in (Lee, 2006)). Consistent with a 
dominant role for GluA1 in mediating synaptic potentiation, GluA1 knockout mice 
(Zamanillo et al., 1999), as well as mice lacking specific phosphorylation sites on 
GluA1 (Lee et al., 2003), display LTP deficits. On the other hand, NMDAR-
dependent LTD is associated with an activity-dependent removal of synaptic 
AMPARs (Carroll et al., 2001). This process depends on endocytosis of GluA2-
containing receptors (Luthi et al., 1999; Daw et al., 2000; Lin et al., 2000; Man et al., 
2000; Osten et al., 2000; Kim et al., 2001a; Lee et al., 2004), but also requires 
dephosphorylation at GluA1-S845 (Lee et al., 1998; Lee et al., 2000a; Lee et al., 
2003). 
While regulation of synaptic AMPARs, through synaptic targeting and 
phosphorylation, is involved in the initial expression of LTP and LTD, maintenance 
of these forms of plasticity involve additional mechanisms. Collectively, data from 
many studies report that blocking new protein synthesis inhibits the late phase of 
long-term synaptic plasticity (Krug et al., 1984; Stanton and Sarvey, 1984; Frey et al., 
1988; Huber et al., 2000; Manahan-Vaughan et al., 2000; Kelleher et al., 2004). This 




memory in intact animals (Flexner et al., 1963; Davis and Squire, 1984) (see 
review(Sutton and Schuman, 2006)). Transcriptional activation is also necessary for 
the maintenance of some forms of long-term synaptic plasticity (Nguyen et al., 1994). 
So far, it is known that multiple transcription factors are activated immediately after 
induction of LTP. Increased transcription of several immediate early genes (IEG) is 
especially important (Tischmeyer and Grimm, 1999) since they enhance new protein 
synthesis (Lynch, 2004; Barco et al., 2006). Interestingly, some, if not all, of these 
transcriptional regulators are also required for long-term memory formation. 
Disruption of cAMP Response Element-Binding Protein (CREB) levels, a Ca2+-
dependent transcription factor, in either the hippocampus or the amygdala has been 
found to impair specific long-term memory but not initial acquisition or short-term 
memory formation (Guzowski and McGaugh, 1997; Lamprecht et al., 1997; Silva et 
al., 1998). Inhibiting the expression of Arc/Arg 3.1 (activity-regulated cytoskeletal 
protein/activity regulated gene 3.1), one of the immediate early genes (IEGs), in the 
hippocampus also impairs long-term memory consolidation (Guzowski et al., 2000). 
Subsection 4 Exogenous Aβ application alters synaptic function 
Molecular understanding of AD came from studying familial AD (FAD)-
linked mutations which have been found in genes encoding APP and presenilin 1 and 
2 (PS1 and 2) in AD patients. These mutations are linked to elevated Aβ production 
(Scheuner et al., 1996; Lendon et al., 1997). This is because many FAD-linked 
mutations make APP a more favorable substrate for the amyloidogenic cleavage 
pathway leading to increased Aβ production. Since FAD patients often harbor 




However, depending on the combination of the mutations and their variants, distinct 
phenotypes are observed across age and brain regions studied (for an extensive recent 
review on electrophysiological studies of various AD transgenic (Tg) mouse models 
see (Marchetti and Marie, 2011)). 
Although different AD mouse models show deficits in synaptic function, it 
cannot be taken for granted that these deficits are caused directly by the enhanced 
production of Aβ peptides (especially the Aβ42, which is the major component of 
extracellular senile plaques). In order to directly test the role of Aβ in altering 
synaptic function, many studies have been done to characterize synaptic properties 
and synaptic plasticity following exogenous application of various Aβ peptides.  
In vitro studies done in either the medial perforant path to dentate granule 
cells or the Schaffer collateral inputs to CA1 neurons, reported that application of 
subneurotoxic concentrations of Aβ peptides (i.e. Aβ42, Aβ40, or Aβ25-35) inhibits LTP 
induction without affecting basal synaptic transmission (Chen et al., 2000; Chen et al., 
2002; Zhao et al., 2004). A similar result was found in an in vivo study, where 
naturally secreted Aβ collected from cells expressing mutated APP (V717F mutation 
in APP751) was injected into the CA1 region of hippocampus which prevented stable 
LTP maintenance (Walsh et al., 2002). This study further showed that soluble Aβ 
oligomers are responsible for blocking LTP, not monomeric Aβ, or Aβ fibrils (Walsh 
et al., 2002). In addition, in vivo injection of Aβ peptides (i.e. Aβ42 or the C-terminal 
of APP containing the Aβ fragment) is reported to facilitate LTD and LTP reversal 
(called depotentiation) in the CA1 region (Kim et al., 2001b). A majority of studies 




hallmark of AD, it is the soluble Aβ oligomers that disturb synaptic function and lead 
to neurodegeneration in AD (Walsh et al., 2002; Tanzi, 2005).  
How is Aβ affecting long-term synaptic plasticity? Soluble Aβ oligomers in 
AD brains have been found to bind to neuronal surfaces (Gong et al., 2003), 
specifically to a subset of synapses where they colocalize with a postsynaptic density 
marker PSD95 (Lacor et al., 2004), suggesting that Aβ may regulate postsynaptic 
function directly. One candidate target of Aβ is NMDARs. It was found that synthetic 
Aβ40 peptides can selectively augment NMDAR current, without affecting AMPAR 
current, in the dentate gyrus of acute hippocampal slices (Wu et al., 1995). Consistent 
with this, APPInd (V717F mutation) Tg mice show an enhancement in the ratio of 
NMDAR-to-AMPAR-mediated synaptic transmission in the CA1 region (Hsia et al., 
1999). However, contradictory results are reported from later studies. A recent study 
showed that both application of synthetic Aβ42 peptides and naturally secreted Aβ, 
from APPSwe (K670N/M671L mutation) Tg mice, promote endocytosis of surface 
NMDARs and hence depresses NMDAR current in wildtype cultured cortical neurons 
(Snyder et al., 2005). Moreover, they also found reduced surface expression of 
NMDARs in cultured cortical neurons from APPSwe Tg mice (Snyder et al., 2005). 
Other studies found down-regulation of surface AMPARs in neurons overexpressing 
either wildtype or APPSwe, or when wildtype neurons were treated with exogenous 
Aβ42 peptides (Almeida et al., 2005; Hsieh et al., 2006). The mechanisms involved 
are not only endocytosis of synaptic AMPARs via mechanisms shared by LTD (Hsieh 
et al., 2006), but also a reduction of basal levels of S845 phosphorylation by 




extrasynaptic delivery of AMPARs (Minano-Molina et al., 2011). Contradictory 
results on the effects of Aβ on AMPAR and NMDAR regulation may be due to 
several variables. First, there is evidence that Aβ40 and Aβ42 peptides may have 
distinct functions in AD pathology. For example, a majority of FADs caused by PS1 
mutations have reduced Aβ1-40 peptides and therefore an increase in the Aβ42/Aβ40 
ratio (Borchelt et al., 1996; Thinakaran and Sisodia, 2006). Second, there are 
differences in experimental preparations. Both Wu et al. (Wu et al., 1995) and Hsia et 
al. (Hsia et al., 1999) were working with acute adult hippocampal slices, while 
Snyder et al. (Snyder et al., 2005), Almeida et al.(Almeida et al., 2005), Hsieh et 
al.(Hsieh et al., 2006) and Minano-Molina et al. (Minano-Molina et al., 2011) were 
using either cultured neurons from embryonic mice or organotypic hippocampal slice 
cultures prepared from early postnatal mice. Third, the presence or absence of APP 
itself may have also affected the results. Indeed there is evidence that uncleaved full-
length APP may promote synapse formation and enhance excitatory synaptic function 
(see (Hoe et al., 2012)for a recent review). 
In any case, Aβ mediated alterations in NMDAR function suggests that Aβ 
will affect downstream Ca2+-dependent signaling pathways. Calcineurin, a Ca2+-
activated protein phosphatase, may be one of the downstream signaling molecules 
affected by Aβ, since it is required for the inhibition of perforant pathway LTP (Chen 
et al., 2002), endocytosis of surface AMPARs (Hsieh et al., 2006), as well as 
dephosphorylation of GluA1-S845 (Minano-Molina et al., 2011). In addition to 
activating calcineurin, Aβ prevents the activation of CaMKII, a Ca2+-dependent 




which correlates with a reduction in the phosphorylation of GluA1-S831, surface 
expression of GluA1, and AMPAR mediated EPSCs (Zhao et al., 2004; Gu et al., 
2009). Together, these data are consistent with the idea that Aβ oligomers impair LTP 
and facilitate LTD (Lee et al., 2000a; Knobloch et al., 2007; Li et al., 2009). 
Aβ has also been found to modify regulation of gene expression. Aβ peptides 
have been found to alter CREB signaling, which causes synaptic dysfunction and 
memory deficits (reviewed in (Saura and Valero, 2011)).In addition, treating cultured 
hippocampal neurons with soluble Aβ oligomers induces rapid expression of the IEG 
Arc/Arg 3.1 (Lacor et al., 2004), which is implicated in synaptic plasticity (Guzowski 
et al., 2000; Steward and Worley, 2001; Shepherd et al., 2006). Because 
overexpression of Arc/Arg 3.1 causes learning dysfunctions (Guzowski, 2002), 
possibly via reducing surface expression of GluA1-containing AMPARs (Shepherd et 
al., 2006), this would suggest that Aβ oligomer-induced Arc/Arg3.1expression may in 
fact interfere with synaptic plasticity. However, this study is seemingly at odds with 
the results of Echeverria and colleagues, which reported a strong inhibition of BDNF-
induced increase in Arc expression in cultured cortical neurons treated with Aβ 
oligomers (Echeverria et al., 2007). Similarly, there is also a report that synaptic 
plasticity related genes, including Arc/Arg3.1, are reduced in transgenic mice 
expressing FAD-linked mutations in APP and PS1 (Dickey et al., 2003). The apparent 
differences in Arc expression caused by Aβ could be due to different experimental 
systems, or that Aβ may modulate Arc expression via distinct pathways which may 




Besides influencing postsynaptic function, Aβ is also implicated in 
presynaptic modifications. A recent study reported that 8 nM Aβ42 globulomer (a 
highly stable globular oligomeric Aβ) could directly inhibit presynaptic P/Q type Ca2+ 
channels and decrease vesicle release (Nimmrich et al., 2008). Moreover, application 
of synthetic Aβ to cultured hippocampal neurons causes a down-regulation of 
dynamin, a protein critical for synaptic vesicle endocytosis, and interrupts synaptic 
vesicle recycling (Kelly et al., 2005; Kelly and Ferreira, 2007). This result is 
consistent with the observed reduction in dynamin levels in human AD brains (Yao et 
al., 2003). These findings may explain the observation that Aβ42 globulomer causes a 
decrease in basal synaptic transmission at the Schaffer collateral to CA1 synapses in 
hippocampal slice culture (Nimmrich et al., 2010). Recently, Kelly et al. reported that 
the reduction in dynamin is dependent on Ca2+ influx through activated NMDARs as 
well as activation of a calcium-activated intracellular cysteine protease calpain (Kelly 
et al., 2005; Kelly and Ferreira, 2006). These results not only suggest that there may 
be retrograde signaling from postsynaptic to presynaptic terminals, but also establish 
an interesting relationship between Aβ, NMDARs and calpain. It has been found that 
Aβ42 peptides can activate calpain-mediated cleavage of p35 to p25 (Lee et al., 
2000b), which then upregulates mRNA and protein expression of β-secretase 
(BACE1) (Wen et al., 2008; Liang et al., 2010), a critical enzyme for Aβ formation 
(discussed in the following sections). This indicates that there is a positive feedback 
between Aβ production and calpain activation. The observation that calpain inhibitors 
can fully recover deficits in basal synaptic transmission caused by Aβ globulomer 




NMDAR antagonist (Nimmrich et al., 2010), suggests that Aβ induced activation of 
NMDARs and calpain may share a common pathway. It is likely that Aβ induces 
Ca2+ influx through NMDARs and activates intracellular calpain, which further 
promotes p25/cdk5 dependent transcription of downstream genes, including BACE1 
(Wen et al., 2008).  
In addition to NMDARs, recent studies suggest that the α7-nicotinic 
acetylcholine receptor (α7-nAChR), a Ca2+-permeable homopentameric ion channel 
highly expressed in the hippocampus and cerebral cortex (Seguela et al., 1993), is 
another potential target of Aβ. High affinity binding between Aβ42 peptides and α7-
nAChRs (Wang et al., 2000b; Wang et al., 2000a) either inhibit (Guan et al., 2001; 
Liu et al., 2001a; Pettit et al., 2001; Chen et al., 2006) or activate α7-nAChR 
signaling (Dineley et al., 2001). It is possible that Aβ42 peptides may facilitate α7-
nAChRs at low concentrations, but may inhibit α7-nAChRs when the burden of Aβ 
increases (Dineley et al., 2001; Dougherty et al., 2003). This concentration-dependent 
dual role of Aβ42 peptides is also suggested from a study showing that picomolar 
concentrations of synthetic Aβ42 peptides facilitate, but nanomolar concentrations 
abolish, hippocampal LTP and learning via their interaction with α7-nAChRs (Puzzo 
et al., 2008).  
Moreover, the double-edged sword effect of Aβ is also reflected by its ability 
to regulate reactive oxygen species (ROS). ROS have been found to have normal 
physiological roles in maintaining normal synaptic plasticity. However, high levels of 
ROS have been found in both AD animal models and human patients, leading to 






Figure 1.2. Aβ is double-edged sword on synaptic function.  
At normal physiological levels (picomolar range), Aβ peptides have positive 
effects on synaptic function: they can facilitate learning and LTP in CA1 by 
activating α7-nAChRs. However, under pathological conditions, such as 
increased neuronal activity, stress or the presence of familial Alzheimer’s disease 
(FAD) mutations, the increase in Aβ peptide concentration produces pathological 
effects, including decreased basal synaptic transmission, decreased presynaptic 
release, LTP impairment and LTD facilitation. Therefore, maintaining the 
concentration of Aβ peptides within a normal physiological level is essential, 
which should be the goal for developing effective treatments for Alzheimer’s 
disease. 
Recently, Ma and colleagues found that exogenous treatment of Aβ42 (500 nM) 
increased mitochondria superoxide, which they reported is a cause of synaptic 
dysfunction induced by Aβ. In particular, decreasing the level of mitochondrial 
superoxide reversed Aβ-induced CA1 LTP impairments (Ma et al., 2011). Given the 
normal physiological role of Aβ and ROS at low levels, this finding suggests that 
ROS imbalance, caused by Aβ toxicity, may lead to synaptic dysfunction in AD. Also, 
it implies that Aβ levels exceeding the normal range may initiate the abnormalities in 





In summary, pathologically high levels of Aβ can disturb ROS balance and 
interfere with both pre- and postsynaptic function, presumably by affecting NMDARs, 
presynaptic P/Q Ca2+ channels, and/or α7-nAChRs; thereby interrupting subsequent 
Ca2+ signaling leading to altered synaptic function. 
Subsection 5 Neuronal activity can regulate APP processing and Aβ levels 
Data from both transgenic mice and exogenous Aβ application studies suggest 
that alterations in Aβ levels change neuronal activity and synaptic function. It is now 
evident that neuronal activity itself can also regulate APP processing leading to 
alterations in Aβ production. In 1993, a study reported that electrical stimulation not 
only increases neurotransmitter release in rat hippocampal slices, but also enhances 
the release of APP cleavage products (Nitsch et al., 1993). In agreement with this 
finding, ten years later, Kamenetz and colleagues (Kamenetz et al., 2003) found that 
neuronal activity can bidirectionally control Aβ levels in organotypic hippocampal 
slice cultures from APPSwe Tg mice. Blocking neuronal activity in this preparation by 
tetrodotoxin (TTX) treatment reduced Aβ levels, while increasing neuronal activity 
with picrotoxin (PTX) enhanced Aβ secretion (Kamenetz et al., 2003). The 
experimental paradigm used by Kamenetz et al. to manipulate neuronal activity is 
reported to produce homeostatic synaptic plasticity termed “synaptic scaling” 
(Turrigiano et al., 1998), which globally up- or down-regulates all excitatory synaptic 
synapses following prolonged decrease or increase, respectively, in neuronal activity 
(Turrigiano and Nelson, 2004). This suggests that Aβ may play a role in regulating 
homeostasis of excitatory synapses in normal brains. In addition, the cellular 




to neuronal activity, is possibly through enhancing the accessibility of APP to γ-
secretase cleavage (Kamenetz et al., 2003) and/or depressing γ-secretase function 
(Lesne et al., 2005). It has recently been shown that PS1, the catalytic subunit of the 
γ-secretase complex, is necessary to scale up excitatory synapses following reduced 
network activity and that PS1 knockout mice show deficits in synaptic scaling (Pratt 
et al., 2011). Moreover, Wu and colleagues have reported that the IEG Arc is required 
for activity-dependent increases of Aβ production (Wu et al., 2011). They found that 
Arc directly binds the N terminus of PS1 and plays an important role in trafficking γ-
secretase to early endosomes where APP is processed through β-secretase pathway to 
produce Aβ. In addition, Arc contributes to Aβ levels and plaque load in 
APPswe;PS1ΔE9 AD mice, and Arc expression is elevated in medial frontal cortex of 
AD patients (Wu et al., 2011). These results provide cellular mechanism of Aβ 
generation coupled to neuronal activity, and may explain why people who suffer from 
hypoxia, which usually causes an abnormal enhancement in neuronal activity (Talos 
et al., 2006), have a higher risk for developing AD (Desmond et al., 2002). 
Consistent with the idea that Aβ induces homeostatic adaptation to increase in 
activity, in vivo studies have also shown that either electrical stimulation or 
endogenous whisker activity proportionally regulate interstitial fluid (ISF) Aβ levels 
in Tg2576 mice, which overexpress human APP carrying the Swedish 
(K670N/M671L) mutation (Cirrito et al., 2005; Cirrito et al., 2008; Bero et al., 2011). 
However, there are also contradictory results. Tampellini et al. have shown that 
synaptic activity decreases intracellular Aβ in primary neuronal culture, as well as in 




carrying the Swedish (K670N/M671L) and Indiana (V717F) mutations (Li et al., 
2004a), likely by enhancing Aβ degradation (Tampellini et al., 2009). Zhang et al. 
have reported that prolonged olfaction deprivation facilitates amyloid plaque 
deposition in the olfactory bulb and piriform cortex of 7-24 month old Tg2576 mice 
(Zhang et al., 2010). These contradictions may be due to age, region, and paradigm 
differences. Another possibility is that normal neuronal activity regulates Aβ levels 
by balancing Aβ release and degradation, and that either hyperactivity or hypoactivity 
may break this balance leading to Aβ accumulation. 
Subsection 6 Physiological roles of APP and Aβ 
Proteolytic processing of APP not only produces Aβ peptides, but also other 
products. Some functions of these products have been identified (reviewed in 
(Pearson and Peers, 2006)). For example, the cytoplasmic tail of APP, APP 
intracellular domain (AICD), is shown to participate in transcriptional regulation 
(Cao and Sudhof, 2001). To evaluate other physiological roles of APP, mice lacking 
APP were generated. APP knockouts show enhanced excitatory synaptic activity and 
neurite growth (Priller et al., 2006), which is consistent with the finding that APP-
deficient mice are more susceptible to glutamate-induced toxicity (Steinbach et al., 
1998). Similar to APP, Aβ peptides also have normal physiological functions. Normal 
physiological levels (picomolar range) of Aβ peptides regulate synaptic function by 
facilitating learning and LTP in CA1 (Puzzo et al., 2008). Additionally, preventing 
Aβ production by adding β- or γ-secretase inhibitors in cultured neurons causes cell 
death, which can be rescued by applying synthetic Aβ peptides to culture medium 




has been identified as a negative feedback regulator of excitatory synaptic 
transmission (Kamenetz et al., 2003).   
Collectively, these data suggest that proteolytic processing of APP and the 
presence of a physiological dose of Aβ may be required for maintaining proper 
neuronal activity and brain function. While the therapeutic benefits of targeting APP 
processing and Aβ production are still attractive, it should be noted that AD 
pathology is most likely triggered only when Aβ levels exceed the normal range, and 
that the physiological processing of APP and Aβ production may be important in 
maintaining normal brain functions. Therefore, partial inhibition, but not complete 
blockade, of Aβ production might be a useful approach for AD therapeutics. A recent 
study supports this view. Immunizing APPInd Tg mice against Aβ, which lowered Aβ 
levels, decreased senile plaque formation, and rescued loss of neuronal integrity seen 
previously in aged mice (Buttini et al., 2005). 
Subsection 7 Role of BACE1 in synaptic function 
As mentioned in Subsection 1, Aβ peptides are generated from sequential 
cleavage of APP by β- and γ-secretase (Fig. 1.1). In the brain, beta-site APP cleaving 
enzyme (BACE1), a transmembrane aspartic protease, has been found to be the major 
neuronal β-secretase (Vassar et al., 1999; Cai et al., 2001; Luo et al., 2001; Roberds et 
al., 2001). Mice lacking the BACE1 gene show no β-secretase activity and essentially 
no Aβ (Aβ40 and Aβ42) production in the brain compared to wildtype littermates. 
Initial characterization of BACE1 knockouts (BACE1 KOs) showed that they are 
viable and fertile, with no gross differences in behavior and development (Cai et al., 




knocking out the BACE1 gene in mouse models of AD was able to rescue 
hippocampus-dependent memory deficits (Ohno et al., 2004; Laird et al., 2005; Ohno 
et al., 2006) and ameliorate impaired hippocampal cholinergic regulation of neuronal 
excitability (Ohno et al., 2004). These findings were quite encouraging and suggested 
that BACE1 may be a good therapeutic target for treating AD (Citron, 2002; Vassar, 
2002; Citron, 2004b). 
However, recent studies have found that BACE1 has normal physiological 
functions in synaptic transmission and plasticity in CA1 region of hippocampus. 
Laird et al. found that BACE1 KO mice display deficits in both synaptic transmission 
and plasticity at the hippocampal Schaffer-Collateral to CA1 synapses (Laird et al., 
2005). While BACE1 KO mice display normal AMPAR- and NMDAR-mediated 
synaptic transmission, these synapses show a larger paired-pulse facilitation (PPF) 
ratio compared to wildtype littermates when tested with paired-pulse stimuli at a 
50ms interstimulus interval (Laird et al., 2005). Changes in PPF ratio are linked to 
alterations in presynaptic function (Manabe et al., 1993). Therefore, the increase in 
PPF ratio observed in BACE1 KO mice, indicates a reduction in presynaptic function, 
which is consistent with the high expression of BACE1 in presynaptic terminals 
(Laird et al., 2005). In addition to reflecting presynaptic changes, recent data suggest 
that alterations in PPF ratio can also be caused by postsynaptic modifications, such as 
by varying the subunit composition of AMPARs (Rozov et al., 1998). Therefore, it is 
possible that knocking out of BACE1 may also affect postsynaptic AMPAR function. 
Besides alterations in the PPF ratio, BACE1 KO mice also showed a larger de-




at the Schaffer collateral inputs to CA1 (Laird et al., 2005). In contrast, the same TBS 
protocol induced-LTP remained unchanged (Laird et al., 2005). As LTP and de-
depression have separate underlying mechanisms (Lee et al., 2000a), these data 
suggest BACE1 may play a regulatory role in the de-depression pathway, while not 
affecting the mechanisms that lead to LTP.  Laird and colleagues also found evidence 
that the enhanced de-depression is due to larger summation of responses during TBS, 
specifically following LTD induction. Enhanced summation of synaptic responses 
during the induction of de-depression despite normal basal synaptic transmission 
suggests that BACE1 may play a specific role in activity-dependent high frequency 
information transfer across synapses. Also, the abnormal increase in the magnitude of 
de-depression reflects that LTD expression may be easily disrupted when knocking 
out BACE1, which could interfere with memory formation and storage. Consistent 
with this interpretation, detailed behavioral studies on BACE1 KO mice reported 
problems in both cognitive and emotional memory tests (Harrison et al., 2003; Laird 
et al., 2005; Ma et al., 2007). Although the majority of studies characterizing synaptic 
function of BACE1 KOs have been performed in the CA1 region of hippocampus 
(Ohno et al., 2004; Laird et al., 2005; Ma et al., 2007), the expression of BACE1 is 
most prominent in the CA3 area of hippocampus (Laird et al., 2005; Zhao et al., 
2007). Therefore, it is essential to investigate the synaptic alteration caused by 
BACE1 inhibition in CA3 area, which is the main focus of my thesis.  
Since synaptic deficits are seen in the CA1 region of hippocampus in BACE1 
KO mice, it indicates that BACE1 may play a general role in regulating synaptic 





Figure 1.3. The roles of BACE1 in synaptic function. 
Besides cleaving APP to produce Aβ peptides, BACE1 has been found to have 
other substrates. It can process the β2 subunit of voltage-gated sodium (Na+) 
channel, which can regulate Na+ channel surface expression and in turn modulate 
neuronal excitability. In addition, BACE1 can cleave NRG1 which plays a crucial 
role in myelination and NRG1/ErB4 signaling. Recently, it has been showed that 
NRG1 can regulate the cell surface expression of α7-nAChRs, which can also 
affect synaptic transmission. 
APP processing is unclear. From the view that Aβ suppresses synaptic transmission 
(discussed in Subsection 4), it seems counterintuitive that abolishing Aβ production, 
as in BACE1 KO mice, would reduce presynaptic function. However, considering the 
fact that physiological concentration of Aβ (pM range) facilitates synaptic plasticity 
(Puzzo et al., 2008), the absence of Aβ could produce synaptic deficits. An alternative 
possibility is that the synaptic dysfunction of BACE1 KO mice may arise from 








It has been shown that the auxiliary β2 subunit of the voltage-gated sodium 
channel (Nav1), is a substrate of BACE1 (Wong et al., 2005; Kim et al., 2007). The 
β2 subunit of the Nav1 channel is important for plasma membrane expression of 
functional Na+ channels, which is critical for generating action potentials. Among the 
ten different types of Nav1 channels, Nav1.1, Nav1.2, Nav1.3 and Nav1.6 are expressed 
mainly in the central nervous system (CNS) (Lai and Jan, 2006). By cleaving the β2 
subunit, BACE1 regulates the surface expression of these types of Nav1 channels. In 
transgenic mice over-expressing BACE1, there is an increase in Nav1.1 α-subunit 
mRNA and protein levels, but a decrease in the surface expression of functional 
Nav1.1 channels due to cleavage of the β2 subunits (Kim et al., 2007; Kim and 
Kovacs, 2011). The interpretation is that the full-length β2 subunit promotes surface 
expression of Nav1.1 channels, but the β2-intracellular domain (ICD), which is 
produced by a sequential cleavage by BACE1 and γ-secretase, increases transcription 
of the Nav1.1 α-subunit gene. Consistent with this, BACE1 KO mice display a 
decrease in Nav1.1 α-subunit mRNA and protein (Kim et al., 2011). However, there is 
a compensatory increase in the surface expression of Nav1.2 in the BACE1 KO mice, 
which correlates with the hyperexcitability and seizure phenotypes seen in BACE1 
KOs (Hu et al., 2010). These results suggest that the ability of BACE1 to regulate the 
Nav1 family of Na+ channels is rather complex, but suggests a role for BACE1 in 
regulating neuronal excitability.  
Another candidate substrate for BACE1 is neuregulin-1 (NRG1), which is an 
axonal signaling molecule critical for regulating myelination (Lemke, 2006). Willem 




nerves (Willem et al., 2006), while another study detected loss of myelination in the 
central nerves (Hu et al., 2006). Both of these studies showed an accumulation of 
unprocessed NRG1 and a reduction in its cleavage products, suggesting that NRG1 is 
a potential substrate for BACE1 cleavage and that this process is important for 
myelination of axons (Hu et al., 2006; Willem et al., 2006). Recently, it has been 
shown that the absence of NRG1 processing in BACE1 KO mice decreased 
postsynaptic function of ErbB4, a receptor for NRG1 (Savonenko et al., 2008). 
NRG1/ErbB4 signaling has been suggested to regulate synaptic function and 
plasticity, mainly via regulation of postsynaptic glutamate receptors(Huang et al., 
2000; Gu et al., 2005b; Li et al., 2007). Additionally, abnormal processing of NRG1 
may also affect presynaptic release by regulating the expression of α7-nAchRs (Liu et 
al., 2001b; Zhong et al., 2008), which allows Ca2+ influx (Seguela et al., 1993).  
Indeed, presynaptic nAChRs can increase glutamate release (McGehee et al., 1995; 
Gray et al., 1996; Maggi et al., 2003a), likely via the α7 containing nAchRs (Le 
Magueresse et al., 2006). These results suggest that the abnormal NRG1 cleavage 
caused by BACE1 inhibition can alter synaptic function both pre- and 
postsynaptically. 
Accumulating data on the biological roles of BACE1 suggest caution for using 
BACE1 inhibitors as a treatment for AD. More and more studies indicate that 
complete inhibition of BACE1 activity is deleterious for neuronal function. In order 
to improve the development of effective therapeutics that target this enzyme, we need 







Figure 1.4. A sketch of hippocampal CA3 circuitry. 
Mossy fibers (MF) form glutamatergic excitatory synapses onto CA3 pyramidal 
cells (PCs) (1) as well as onto inhibitory interneurons (INTs) (2) in the stratum 
lucidum; inhibitory neurons project GABAergic synapses onto CA3 PCs (3). This 
configuration is feedforward inhibition, in which PCs and INTs are excited 
simultaneously by common afferents (MF inputs), with INTs in turn inhibiting 
PCs with a short delay relative to the monosynaptic excitation. 
Section 2 Synaptic plasticity at mossy fiber synapses 
As one of the three important pathways in hippocampus, the mossy fiber 
pathway is composed of dentate gyrus granule cell axon projections, the so called 
mossy fibers on dendrites of pyramidal cells within the stratum lucidum of CA3 area 
and the filopodial extensions from mossy fiber boutons, which contact inhibitory 
interneurons forming feedforward inhibition in local CA3 circuitry (Chicurel and 
Harris, 1992; Acsady et al., 1998) (Fig. 1.4). Although they are originated from 
common mossy fiber input, synapses on CA3 pyramidal cells and those on CA3 





Subsection 1 Mossy fiber at CA3 pyramidal cell synapses 
i) Short-term plasticity 
The axons of the dentate gyrus granule cells innervate their pyramidal neuron 
targets via giant mossy fiber boutons which have multiple active zones (Chicurel and 
Harris, 1992; Henze et al., 2000). The mossy fiber synapse onto CA3 pyramidal cells 
is distinct from most other synapses in the CNS due to its large paired-pulse 
facilitation (PPF) and uniquely robust frequency facilitation (Salin et al., 1996), 
which are presynaptic forms of short-term plasticity. The large PPF and robust 
frequency facilitation are consistent with a low probability of neurotransmitter release 
at these synapses (Jonas et al., 1993; Lawrence et al., 2004). 
CA3 pyramidal cells not only receive mossy fiber inputs, they also receive 
inputs from other CA3 pyramidal cells, forming associational-commissural synapses. 
Associational inputs are the projections from other CA3 pyramidal cells on the same 
side of the brain, commissural inputs are CA3 - CA3 connections between the two 
hemispheres. Unlike mossy fiber synapses onto CA3 pyramidal cells, associational-
commissural synapses show very little facilitation (Salin et al., 1996; Dobrunz and 
Stevens, 1999), suggesting a stronger presynaptic release.  
ii) Long-term potentiation 
In striking contrast to LTP in CA1 region of hippocampus discussed in 
Section 1, high frequency stimulation induced mossy fiber LTP is a presynaptic form 
of LTP, which is NMDAR independent (Harris and Cotman, 1986). As early as 1994, 
Weisskopf and colleagues reported that the mechanism of mossy fiber LTP is 




by Ca2+ influx in response to high frequency stimulation at mossy fiber terminals. The 
increased Ca2+ activates calmodulin, which in turn stimulates adenylyl cyclase, 
therefore increasing cAMP level and activating cAMP dependent protein kinase A 
(PKA). PKA phosphorylation of specific synaptic vesicle proteins facilitates 
presynaptic vesicle release, which results in a long-lasting increase in presynaptic 
release. Recent studies have indicated several PKA phosphorylation targets that are 
indispensable for mossy fiber LTP. The synaptic vesicle protein Rab3A is required 
for mossy fiber LTP as shown by an absence of mossy fiber LTP in mice lacking 
Rab3A (Castillo et al., 1997). In addition, Lonart et al. identified that RIM1α, an 
active zone protein that binds to Rab3A, is a PKA substrate that is necessary to 
presynaptic LTP (Lonart et al., 2003). Another candidate of PKA phosphorylation is 
Rabphilin, an effector protein of Rab3A, PKA phosphorylation of Raphilin is 
specifically detected in CA3 region in response to LTP induction compared to CA1 
(Lonart and Sudhof, 1998).  
Although LTP at mossy fiber terminals on CA3 pyramidal cell synapses is 
widely accepted as a presynaptic form of LTP, recently it has been found that 
NMDAR dependent LTP can also be induced by relative weak stimulation at these 
synapses. Kwon and colleagues found that this form of LTP is not due to an increase 
in presynaptic release probability. In contrast to the “classical” mossy fiber LTP, the 
induction of NMDAR dependent mossy fiber LTP requires not only NMDAR, but 
also mGluR5 activation, which stimulates postsynaptic PKC pathway, and further 
induces postsynaptic Ca2+ release from internal Ca2+ store (Kwon and Castillo, 




significance. Given the slow kinetics of NMDAR-mediated synaptic responses, 
NMDAR mediated mossy fiber LTP could modify the temporal nature of synaptic 
integration in CA3 pyramidal cells. Moreover, it has been reported that selective 
removal of NMDAR NR1 subunit from CA3 pyramidal cells by genetic manipulation 
has an important impact on memory acquisition (Nakazawa et al., 2003), associative 
memory recall, and pattern completion (Nakazawa et al., 2002), contextual learning 
(Cravens et al., 2006), and trace conditioning learning (Kishimoto et al., 2006). 
Before NMDAR mediated mossy fiber LTP was discovered, it is commonly assumed 
that NMDARs at associational - commissural synapses mediate this effect on learning 
and memory, but with Kwon and colleagues’ finding, it suggests that NMDARs at 
mossy fiber CA3 pyramidal neuron synapses may also contribute. 
iii) Long-term depression 
Metabotropic glutamate receptor 2 (mGluR2), one of Group-II mGluRs, is 
found primarily at the presynaptic terminals of mossy fiber-CA3 pyramidal cell 
synapses (Yokoi et al., 1996). These receptors are thought to suppress transmission in 
response to excess glutamate release (Scanziani et al., 1997), and also play an 
essential role in inducing LTD (Kobayashi et al., 1996; Yokoi et al., 1996). The 
mechanistic studies of this form of LTD have found that the G proteins coupled with 
mGluR2 are Gi proteins, which contain an inhibitory αi-type subunit (Pin and 
Duvoisin, 1995; Nicholls et al., 2006). Activation of mGluR2 activates Gi proteins, 
which results in a decrease in adenylyl cyclase activity followed by a decrease in 
PKA activity (Tzounopoulos et al., 1998), which leads to reduction of 




processes involved in mossy fiber LTP. Since mGluR2 is exclusively expressed at 
mossy fiber terminals but not at associational – commissural synapses, detecting the 
existing of mGluR2 can be used to distinguish mossy fiber inputs, therefore, 
(2S,s’R,3’R)-2-(2’,3’-dicarboxycyclopropyl) glycine (DCG-IV), a mGluR2 agonist, 
is commonly applied to suppress synaptic transmission originated from mossy fiber 
terminals (Toth and McBain, 1998; Toth et al., 2000; Torborg et al., 2010). 
Besides mGluR2 mediated LTD, there is another form of LTD existing at 
these synapses. In young animals, it has been reported that high frequency stimulation 
(Domenici et al., 1998) or prolonged depolarization (5 min) in the absence of 
stimulation (Lei et al., 2003) induces LTD that is independent of NMDARs and 
mGluRs, but is dependent on a rise in postsynaptic Ca2+. This LTD coexists with, and 
is mechanistically distinct from, the mGluR-dependent LTD discussed above. 
However, there is disagreement as to whether this form of LTD is expressed 
presynaptically (Domenici et al., 1998) or postsynaptically (Lei et al., 2003). 
Subsection 2 Mossy fiber at CA3 interneuron synapses 
i) Short-term plasticity 
Unlike pyramidal cells which receive inputs from large mossy fiber boutons, 
interneurons within the stratum lucidum are innervated by small en passant or 
filopodial mossy fiber synapses (Acsady et al., 1998). Not only is there structure 
differences, the subunit composition of postsynaptic AMPARs at these two kinds of 
synapses are also different. Whereas mossy fiber onto CA3 pyramidal neuron 
synapses express only calcium-impermeable (CI) AMPARs, which contain the GluA2 




contain both calcium-impermeable (CI) and GluA2-lacking calcium-permeable (CP) 
AMPARs (Toth and McBain, 1998). In addition, pronounced short-term facilitation is 
particularly prominent for the large mossy fiber boutons; mossy fiber terminals 
targeting interneurons show much less frequency facilitation or can even undergo 
depression, which is not due to the subunit composition of postsynaptic AMPARs 
(Toth et al., 2000). However, CP-AMPAR synapses show a voltage-dependent 
facilitation because of relief from blockade by polyamine spermine at these GluA2-
lacking AMPARs (Toth et al., 2000).  
ii) Long-term plasticity 
High frequency stimulation, which induces NMDAR independent LTP at 
mossy fiber to CA3 pyramidal cell synapses, generates NMDAR dependent LTD at 
interneuron CI-AMPAR synapses (Lei and McBain, 2002), and NMDAR 
independent LTD at CP-AMPARs containing synapses on interneurons (Toth et al., 
2000). The induction of both forms of LTD required elevation of postsynaptic Ca2+ 
through NMDAR activation in the case of the former, and CP-AMPAR activation for 
the latter.  
Although early studies failed to show LTP at mossy fiber synapses onto 
interneurons, more recent studies indicate that this form of plasticity can be induced. 
Alle et al. found that high frequency stimulation evokes LTP at mossy fiber synapses 
to dentate basket cells. This LTP is attenuated by high doses of BAPTA in the basket 
cell. Compared to mossy fiber to pyramidal cell LTP, LTP at the mossy fiber to 
dentate basket cell synapses is also expressed presynaptically but is abolished by PKC 




form of LTP at mossy fiber on stratum lucidum interneurons expressing CP-
AMPARs at synapses. In the presence of group III mGluR agonist L-AP4, a brief 
tetanus induces LTP. Surprisingly, this form of LTP actually requires the 
internalization of mGluR7, but not mGluR activity blockade, because a tetanus with 
mGluR7 antagonist application does not induce LTP (Pelkey et al., 2005). 
The differences of synaptic transmission and plasticity at the two types of 
mossy fiber innervated synapses suggest that the regulation of synaptic function at 
these sites is specialized depending on the nature of the postsynaptic target cell. 
The following three chapters, which include two papers I have published in 
Journal of Neuroscience and one paper under preparation, are the result sections of 
my thesis. In Chapter 2 and 3, I used field potential recording as well as whole-cell 
patch-clamp recording to examine the synaptic function of all three synapses within 
CA3 circuit (see Fig. 1.4), and specifically located the synaptic dysfunction of this 
circuit in BACE1 KOs. Furthermore, in Chapter 4, I report that nicotine and alpha-7 





Chapter 2: Beta-amyloid precursor protein cleavage enzyme 1 
(BACE1) knockouts display deficits in activity-dependent 
potentiation of synaptic transmission at mossy fiber to CA3 
synapses in the hippocampus 
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Section 1 Introduction 
Alzheimer’s disease (AD) is the most prevalent form of senile dementia. 
Current treatment of AD remains limited, and there is no effective disease-modifying 
treatment as of yet (Citron, 2004b). It is widely believed that AD is initiated as a 
synaptic dysfunction, which correlates with the loss of memory function in the early 
stages of the disease (Selkoe, 2002). A current hypothesis states that over-production 
of amyloid-beta (Aβ) peptide initiates the pathogenesis of AD (Hardy and Selkoe, 
2002; Citron, 2004b; Walsh and Selkoe, 2007). Aβ is produced from the sequential 
cleavage of amyloid precursor proteins (APPs) by β- and γ-secretases, which are one 
of the major disease-modifying targets to treat AD (Citron, 2004b). However, it 
became apparent that γ-secretase processes other critical substrates essential for 
normal cell development and function, such as Notch (Sisodia and St George-Hyslop, 
2002; Selkoe and Kopan, 2003). Therefore, inhibiting β-secretase is now receiving 
renewed attention (Vassar, 2002; Citron, 2004a, b). The amount and activity of β-
secretase is elevated in sporadic AD brains (Yang et al., 2003; Li et al., 2004b; Zhao 
et al., 2007), further suggesting that effective methods to reduce its activity may be 




A transmembrane aspartic protease, called BACE1 (beta-site APP cleavage 
enzyme 1), was identified as the major neuronal β-secretase (Hussain et al., 1999; 
Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999). BACE1 knockout mice were 
generated to determine the functional consequences of chronically inhibiting the 
activity of β-secretase. Initial characterization of the BACE1 knockouts suggested 
that there are no gross anatomical or functional abnormalities (Luo et al., 2001; Luo 
et al., 2003). Moreover, knocking out BACE1 in APP transgenic lines, which 
normally develop Aβ plaques and behavioral deficits, essentially alleviated the AD 
symptoms (Luo et al., 2003; Ohno et al., 2004; Laird et al., 2005). However, recent 
studies, including our own, showed that BACE1 knockouts display specific 
dysfunctions in synaptic transmission and plasticity (Ohno et al., 2004; Laird et al., 
2005), as well as behavioral deficits (Harrison et al., 2003; Laird et al., 2005; 
Savonenko et al., 2008). While all of the studies characterizing synaptic function of 
BACE1 knockouts so far have been carried out in the CA1 region of the hippocampus 
(Ohno et al., 2004; Laird et al., 2005; Ma et al., 2007), the expression of BACE1 is 
most prominent in the mossy fiber terminals that synapse onto CA3 pyramidal 
neurons (Laird et al., 2005; Zhao et al., 2007). Therefore, we examined synaptic 
function and plasticity of the BACE1 knockouts at the mossy fiber synapses. 
 
Section 2 Methods and Materials 
Subsection 1 Animals 
All mice used (BACE1 +/+ and –/–) were derived from heterozygous breeders 




Use Committees of both University of Maryland at College Park and Johns Hopkins 
University approved all procedures involving animals. 
Subsection 2 Acute hippocampus slices preparation for electrophysiology 
Hippocampal slices were prepared from adult (3-6 months old) male BACE1 
knock-out or wild-type mice as described previously (Laird et al., 2005). Briefly, 
under deep anesthesia by isoflurane, mice were killed by decapitation, and their 
brains were removed quickly and transferred to the ice-cold dissection buffer  
containing the following (in mM): 212.7 sucrose, 2.6 KCl, 1.23 NaH2PO4, 26 
NaHCO3, 10 dextrose, 3 MgCl2, and 1 CaCl2  (bubbled with a mixture of 5% CO2 and 
95% O2). A block of hippocampus was removed and sectioned into 400 µm-thick 
slices using a vibratome. The slices were recovered for 1 h at room temperature in 
artificial CSF (ACSF) (in mM): 124 NaCl, 5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 
dextrose, 1.5 MgCl2, and 2.5 CaCl2 (bubbled with a mixture of 5% CO2 and 95% O2). 
Subsection 3 Electrophysiological Recordings 
Recordings were done in a submersion-type recording chamber perfused with 
ACSF (saturated with 5% CO2/95% O2; 29.5°C–30.5°C, 2 ml/min). Synaptic 
responses were evoked through bipolar stimulating electrodes (double-barreled 
borosilicate glass capillaries [Sutter Instruments, Novato, CA]) placed in the dentate 
granule cell layer to activate the mossy fibers with pulse durations of 0.2 ms (baseline 
stimulation at 0.067 Hz), and recorded extracellularly in the stratum lucidum of CA3. 
Both the stimulating and recording electrodes were filled with ACSF. To induce long-




intervals. Long-term depression (LTD) was induced by a paired-pulse 1Hz protocol 
(interstimulus interval (ISI) = 50 ms, 15min). For measurement of paired-pulse 
facilitation (PPF), ISIs of 25, 50, 100, 200, 400, 1000, and 2000 ms were used. In 
some experiments, extracellular Ca2+ concentration was increased to 5.0 mM for 10 
minutes before delivering HFS (Castillo et al., 2002). To activate cAMP production, 
50 μM forskolin (Sigma-Aldrich, St. Louis, MO) was applied for 5 minutes. All 
experiments were done in the presence of 100 µM D,L-2-amino-5-phosphonovaleric 
acid (D,L-APV) (Sigma-Aldrich, St. Louis, MO) to block NMDA receptors. At the 
end of each experiment, 1 µM (2S,s’R,3’R)-2-(2’,3’-dicarboxycyclopropyl) glycine 
(DCG-IV) (Tocris Bioscience, Ellisville, MI) was added, and blockade ≥ 80% were 
taken to be mossy fiber inputs.  
Subsection 4 Analysis of Electrophysiology data 
The evoked extracellular field potential were digitized and stored in the 
computer by the Igor software (WaveMetrics). Using a custom-made Igor program, 
initial slope (for measurement of AMPA receptor responses) of population field 
potential was measured as the strength of synaptic transmission, and data are 
expressed as mean ± standard error of mean. For statistic, Fisher’s PLSD post hoc test 
was used to compare the PPF ratio. For the LTP and LTD data, the measurements at 
the end of each recording (60 min after baseline for LTP and LTD ) were compared 





Section 3 Results 
Subsection 1 Reduction in presynaptic function at mossy fiber synapses in 
BACE1 knockouts 
We previously observed that mossy fiber terminals are enriched in BACE1 
protein compared to other hippocampal subfields (Laird et al., 2005). Therefore, we 
hypothesized that BACE1 knockouts may exhibit alterations in synaptic transmission 
and plasticity at this particular set of synapses. We first measured presynaptic 
function by comparing paired-pulse facilitation (PPF) ratio at various interstimulus 
intervals (ISIs). We found a significant interaction between the genotype and ISIs 
(Two-factor ANOVA, genotype * ISI: F(6, 203) = 2.586, P < 0.02), particularly 
BACE1 KOs displayed larger PPF ratios at shorter ISIs (25 ms ISI: WT = 3.4 ± 0.57; 
KO = 6.1 ± 0.79; 50 ms ISI: WT = 3.6 ± 0.65, n = 14; KO = 5.7 ± 0.77, n = 17; 
Fisher’s PLSD post hoc test: P < 0.002 for 25 and 50 ms ISI between WT and KO; 
Fig. 2.1A). The increase in PPF ratio suggests a reduction in presynaptic release.  
Pyramidal cells in the CA3 region receive inputs not only from mossy fibers 
but also from CA3 pyramidal cell collaterals. Therefore, it was important to confirm 
in that the recorded field potentials originated from granule cell activation. Group II 
metabotropic glutamate receptors (mGluRs) are expressed exclusively on mossy fiber 
terminals but not on CA3 collaterals (Nicoll and Schmitz, 2005). DCG-IV, a group II 
mGluRs agonist, can therefore be used to identify synaptic transmission at mossy 
fiber to CA3 synapses. Bath application of 1 µM DCG-IV at the end of the recording 




Figure 2.1. BACE1 knockouts 
display a reduction in presynaptic 
function at the mossy fiber 
synapses. 
A. Larger PPF ratio in BACE1 
knockouts. The difference between 
wildtype (WT: white circles) and 
knockouts (KO: black circles) are 
significant at 25 and 50 msec ISIs.  
B. Application of Group II mGluR 
agonist (1 µM DCG-IV) reduces 
mossy fiber synaptic transmission in 
wildtype (white circles) and 
knockouts (black circles). Top: 
Representative field potential (FP) 
traces following paired-pulse 
stimulation at 50 msec ISI before and 
after DCG-IV application in wildtype 
and knockout. 
and wildtypes (WT: 12 ± 4% of baseline at 20 min DCG-IV, n = 14; KO: 11 ± 2%, n 





Subsection 2 Activity-dependent synaptic strengthening at mossy fiber 
synapses is abolished in BACE1 knockouts 
Next we examined whether knocking out BACE1 affects synaptic plasticity at 




stimulation (HFS: 3 x 100 Hz, 1 sec). BACE1 knockouts showed a larger initial 
potentiation, suggesting an enhanced facilitation during HFS, however, the responses 
relaxed back to baseline by 1 hour (WT: 149 ± 10% of baseline at 1 hour post-HFS, n 
= 13 slices/6 mice; KO: 96 ± 7%, n = 16 slices/7 mice; t-test: P < 0.01; Fig. 2.2A). 
Consistent with a presynaptic locus of expression, LTP in wildtypes was 
accompanied by a decrease in PPF ratio measured at 50 ms ISI (baseline = 3.1 ± 0.5, 
1 hour post-HFS = 2.6 ± 0.4, n = 13 slices/6 mice, paired t-test: P < 0.03), but 
knockouts displayed no change in PPF ratio (baseline = 5.9 ± 1.0, 1 hour post-HFS = 
6.1 ± 1.2, n = 16 slices/7 mice, paired t-test: P = 0.26). 
To test LTD, we used a paired-pulse 1 Hz protocol (PP-1 Hz, 15 min), 
because a standard 1 Hz (15 min) protocol (Kobayashi et al., 1996) failed to produce 
LTD in the wildtypes at the ages used for our study (data not shown). LTD induced 
by the PP-1 Hz was slightly larger in BACE1 knockouts (WT: 75 ± 4.3% of baseline 
at 1 hour post-onset of PP-1 Hz, n = 7 slices/5 mice; KO: 62 ± 3.8% of baseline, n = 6 
slices/4 mice; t-test: P < 0.04; Fig. 2.2B). This form of LTD did not significantly 
change PPF ratio either in wildtypes or knockouts (WT: baseline = 3.8 ± 1.0, 1 hour 
post-PP 1 Hz = 3.2 ± 0.9, n = 6 slices/4 mice, paired t-test: P = 0.16; KO: baseline = 
7.1 ± 1.5, 1 hour post-PP 1Hz = 5.5 ± 1.1, n = 6 slices/4 mice, paired t-test: P = 0.10). 
Unlike in wildtypes, HFS failed to reverse LTD in the knockouts (WT: 195 ± 28.0% 
of renormalized baseline at 1 hour post-HFS, n = 6 slices/4 mice; KO: 100 ± 5.4%, n 








Figure 2.2. Absence of activity-dependent potentiation at mossy fiber 
synapses in BACE1 knockouts. 
A. Mossy fiber LTP is absent in BACE1 knockouts. Left: Summary graph 
plotting changes in normalized field potential against time. The arrow depicts 
when HFS (100 Hz, 1 sec x 3) was delivered. Note that knockouts (black circles) 
showed larger post-tetanic potentiation, but no LTP when compared to wildtypes 
(white circles). Middle: Superimposed representative FP traces taken from 
wildtype and knockouts at times indicated in the left panel. Right: Average 
magnitude of LTP at 1-hour post-HFS (last 10 min averages) between wildtype 
and knockouts. 
B. BACE1 knockouts show a slightly larger LTD, but no dedepression. Left 
bottom: Summary graph of the averages. The bar and arrow indicate delivery of 
PP-1 Hz (15 min), and HFS (100 Hz, 1 sec x 3), respectively. Left top: 
Representative FP traces taken at times indicated in the summary graph. Right: 
Average magnitude of dedepression measured 1-hour post-HFS (averages of last 
10 min) between wildtype and knockouts. The responses were re-normalized to 





Subsection 3 Rescue of mossy fiber LTP in BACE1 knockouts by 
increasing extracellular Ca2+ concentration 
Mossy fiber LTP is triggered by a rise in presynaptic Ca2+(Castillo et al., 
1994), and a further recruitment of cAMP-dependent signaling mechanisms (Nicoll 
and Schmitz, 2005). Therefore, we investigated whether the lack of mossy fiber LTP 
in BACE1 knockouts is due to abnormal regulation of presynaptic Ca2+ or signaling 
downstream. We found that transiently increasing the concentration of extracellular 
Ca2+ (from 2.5 mM to 5 mM) during HFS recovered mossy fiber LTP in BACE1 
knockouts (146.7 ± 8.5% of baseline at 1 hour post-HFS, n = 6 slices/4 mice; paired t-
test: P < 0.01; Fig. 2.3). Furthermore, LTP was accompanied by a decrease in PPF 
ratio measured at 50 ms ISI (baseline = 3.8 ± 1.0, 1 hour post-HFS = 2.2 ± 0.4, n = 6 
slices/4 mice, paired t-test: P < 0.05) consistent with a presynaptic expression. This 
suggests that the induction of mossy fiber LTP is defective in the BACE1 knockouts  
To further confirm whether signaling downstream of the Ca2+ influx is intact 
in BACE1 knockouts, we directly activated cAMP signaling by a brief application of 
an adenylyl cyclase activator forskolin. This caused a dramatic enhancement of 
synaptic transmission in both wildtypes and knockouts to similar magnitudes (WT: 
622.5 ± 57.8% of baseline at 1 hour post-forskolin, n = 7 slices/5 mice; KO: 741.8 ± 
110.1%, n = 7 slices/4 mice; t-test: P = 0.36; Fig. 2.3). This was accompanied by a 
significant decrease in PPF ratio in both genotypes (WT: baseline = 3.2 ± 0.34, 1 hour 
post-forskolin = 1.5 ± 0.15, n = 7 slices/5 mice, paired t-test: P < 0.01; KO: baseline = 
4.9 ± 0.63, 1 hour post-forskolin = 1.7 ± 0.16, n = 7 slices/4 mice, paired t-test: P < 




Figure 2.3. BACE1 knockouts 
express mossy fiber LTP 
under high extracellular Ca2+, 
and produce normal 
forskolin-induced 
potentiation.  
A. Transient elevation of 
external Ca2+concentration (5 
mM Ca2+, 10 min; gray bar) 
rescued mossy fiber LTP in 
knockouts. Right: 
Representative traces taken at 
times indicated. 
B. Transient application of 
forskolin (50 µM, 5 min; gray 
bar) potentiated mossy fiber 
synaptic transmission in 
wildtypes (white circles) and 
knocks (black circles) to the 
same magnitude. Top: 
Representative traces taken at 
times indicated. 














Section 4 Discussion 
We found that BACE1 knockouts display severe deficits in presynaptic 
function at mossy fiber synapses in CA3: a reduction in presynaptic release and an 
absence of mossy fiber LTP. In addition, BACE1 knockouts exhibited a slightly 
larger LTD, which could not be reversed. These results suggest that BACE1 function 
is critical for normal synaptic transmission and plasticity, especially activity-
dependent potentiation, at these synapses. We further found that the specific deficit in 
mossy fiber LTP in BACE1 knockouts can be rescued by increasing extracellular 
Ca2+ concentration. Since a direct activation of cAMP production was not impaired in 
the BACE1 knockouts, our data suggests that the presynaptic dysfunction is likely at 
the level of presynaptic Ca2+ regulation. 
Previous studies suggest that BACE1 is highly localized to presynaptic 
terminals, especially at the mossy fiber boutons in the CA3 (Laird et al., 2005; Zhao 
et al., 2007). This localization is consistent with our observation of a deficit in 
presynaptic function and plasticity at this synapse. Taken together with our previous 
results from the CA1 also showing an increase in PPF ratio (Laird et al., 2005), these 
results indicate that BACE1 may play a general role in regulating presynaptic 
function under physiological conditions. However, whether presynaptic deficits in 
BACE1 knockouts are directly due to lacking APP processing is unclear. Previous 
studies suggest that generation of excess Aβ depresses excitatory synaptic 
transmission (Kamenetz et al., 2003; Hsieh et al., 2006; Ting et al., 2007) mainly by 
postsynaptic removal of AMPA receptors and loss of synapses (Hsieh et al., 2006; 




production, as in BACE1 knockouts, would cause a postsynaptic increases in AMPA 
receptor function, not a decrease in presynaptic function as observed in our studies. 
Our previous work in CA1, where BACE1 knockouts showed normal basal synaptic 
transmission despite the apparent reduction in presynaptic release (Laird et al., 2005), 
implies that there may be a compensatory increase in postsynaptic function. 
Another possibility is that the presynaptic effects of BACE1 knockout may be 
from abnormal processing of substrates other than APP. It is now known that BACE1 
can also cleave APP-like proteins (APLPs) (Li and Sudhof, 2004), β subunits of 
voltage-gated Na+ channel (Wong et al., 2005; Kim et al., 2007), and neuregulin-1 
(NRG1) (Hu et al., 2006; Willem et al., 2006). Regulation of the latter two substrates 
is particularly interesting. The β2 subunit of Na+ channel is critical for plasma 
membrane expression of functional Na+ channels (Schmidt and Catterall, 1986), 
which are essential for action potential generation. However, over-expressing BACE1 
actually decreases the density of functional Na+ channels (Kim et al., 2007), hence it 
cannot directly account for the observed reduction in presynaptic release in the 
BACE1 knockouts. Potential regulation of NRG1 by BACE1 was discovered from 
observations that BACE1 knockouts display a hypomyelination phenotype with a 
correlated accumulation of full-length NRG1 and a significant loss of NRG1 cleavage 
products (Hu et al., 2006; Willem et al., 2006). Recently, we demonstrated that the 
lack of NRG1 processing in BACE1 knockouts reduces postsynaptic function of 
ErbB4, a receptor for NRG1 (Savonenko et al., 2008). NRG1/ErbB4 signaling has 
been suggested to regulate synaptic function and plasticity, mainly via regulation of 




Nevertheless, abnormal processing of NRG1 may also affect presynaptic release by 
regulating the expression of nicotinic acetylcholine receptor (nAChR) subunit α7 (Liu 
et al., 2001b), which allows Ca2+ influx (Seguela et al., 1993). Indeed, presynaptic 
nAChRs can increase glutamate release (McGehee et al., 1995; Gray et al., 1996; 
Maggi et al., 2003b), likely via the α7 containing nAChRs (Le Magueresse et al., 
2006). These results suggest that lacking NRG1 cleavage, as in BACE1 knockouts, 
would reduce presynaptic release. Whether this is the case for mossy fiber synapses is 
unclear (Vogt and Regehr, 2001).  
Our results indicate that a complete inhibition of BACE1 activity is 
deleterious for neuronal function, especially at the mossy fiber synapses in CA3 
compared to Schaffer collateral inputs in CA1. This suggests that mossy fiber 
dysfunction may have had a larger impact on the behavioral phenotypes seen in the 
BACE1 knockouts (Harrison et al., 2003; Laird et al., 2005; Savonenko et al., 2008). 
We demonstrate that signaling downstream of presynaptic Ca2+ influx is intact in 
BACE1 knockouts. Therefore, we were able to restore mossy fiber LTP in the 
BACE1 knockouts by simply increasing extracellular Ca2+ concentration during LTP 
induction. This has significant clinical implications, because it suggests that means to 
enhance presynaptic Ca2+ will circumvent synaptic deficits, and perhaps alleviate the 





Chapter 3: Synaptic dysfunctions in the CA3 circuit of BACE1 
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Section 1 Introduction 
Beta-amyloid precursor protein cleavaging enzyme 1 (BACE1), a major 
neuronal β-secretase critical for the formation of β-amyloid (Aβ) peptide, is thought 
to be one of the key therapeutic targets that can prevent the progression of 
Alzheimer’s disease (AD) (Vassar, 2002; Citron, 2004b, a; Vassar et al., 2009). 
However, many recent studies, including my own in Chapter 2, have shown that 
although BACE1 knockouts (KOs) lack Aβ peptides (Cai et al., 2001) and show no 
gross anatomical or functional abnormalities (Luo et al., 2001; Luo et al., 2003), they 
display specific synaptic dysfunctions in CA1 and CA3 regions of the hippocampus 
(Laird et al., 2005; Wang et al., 2008). In particular, we investigated synaptic function 
and plasticity of the BACE1 knockouts using extracellular field recordings, and found 
that BACE1 KOs showed presynaptic dysfunctions especially at the mossy fiber to 
CA3 synapses, which is one of the major loci of BACE1 expression in the brain 
(Laird et al., 2005), we also pinpointed the presynaptic dysfunction of BACE1 KOs to 
the level of presynaptic Ca2+ signaling (Wang et al., 2008). 
The CA3 pyramidal neurons not only receive excitatory inputs from mossy 
fibers, but also get feedforward inhibition formed by the interneurons (INTs) within 




2003). How blocking BACE1 influences excitatory and/or inhibitory synapses in this 
feedforward inhibitory circuit is unknown. Because many of the neuronal functions 
depend on a critical balance between excitatory and inhibitory circuits, understanding 
the impact of BACE1 inhibition on each synapse-type present in an intact circuitry is 
critical. Furthermore, by providing understanding of how a lack of BACE1 activity 
affects specific synapses, it will aid in the development of effective methods to 
overcome the synaptic deficits and potentially benefit the therapeutics of AD. 
Therefore, in this chapter, we expanded the analysis to a circuit level in the CA3 area 
of hippocampus by performing whole-cell recording from pyramidal cells (PCs) and 
inhibitory interneurons (INTs) in the CA3 area that receive mossy fiber inputs to 
examine the mossy fiber (MF) synapses onto CA3 PCs and INTs, as well as 
inhibitory synapses from INTs to CA3 PCs, to specifically locate the synapses 
affected by losing BACE1 activity (see Fig. 1.4 in Chapter 1). 
 
Section 2 Methods and Materials 
Subsection 1 Animals 
All mice used (BACE1 +/+ and –/–) were derived from heterozygous breeders 
(+/–) as described previously (Laird et al., 2005). The Institutional Animal Care and 
Use Committees of both University of Maryland and Johns Hopkins University 




Subsection 2 Acute hippocampus slices preparation for electrophysiology 
Acute hippocampal slices were prepared from 16 - 25 d-old BACE1 KO or 
WT mice as described previously (Laird et al., 2005; Wang et al., 2008). Briefly, each 
mouse was euthanized by decapitation following overdose of isoflurane. Hippocampi 
were rapidly removed and sectioned into either 300-μm (for whole cell recording) or 
400-μm (for field potential recording) slices on a vibratome (Vibratome 3000 series, 
Ted PellaInc.) using ice-cold dissection buffer (212.7 mM sucrose, 2.6 mM KCl, 1.23 
mM NaH2PO4, 26 mM NaHCO3, 10 mM dextrose, 3 mM MgCl2, and 1 mM CaCl2) 
saturated with 5% CO2/95% O2.The slices were transferred to a holding chamber 
containing artificial cerebrospinal fluid (ACSF: 124 mM NaCl, 5 mM KCl, 1.25 mM 
NaH2PO4, 26 mM NaHCO3, 10 mM dextrose, 1.5 mM MgCl2, and 2.5 mM CaCl2, 
saturated with a mixture of 5% CO2/95%O2) and recovered for at least1hat room 
temperature before being used for all experiments. 
Subsection 3 Field Potential Recording from mossy fiber pathway in CA3 
area 
Recordings were done in a submersion-type chamber perfused with ACSF 
(29.5°C–30.5°C, 2 ml/min). Synaptic responses were evoked through glass bipolar 
stimulating electrodes placed in the dentate granule cell layer to activate MFs with 
pulse duration of 0.2 ms (at 0.067 Hz), and recorded extracellularly in the stratum 
lucidum of CA3. Paired-pulse facilitation (PPF) was measured at 25, 50, 100, 200, 
400, 1000, and 2000 ms interstimulus intervals (ISIs). To induce mfLTP, three trains 
of 100 Hz (1 sec) stimuli were given at 20 sec intervals. All experiments were done in 




Aldrich) to isolate the presynaptic NMDAR-independent mfLTP (Nicoll and Schmitz, 
2005). At the end of each experiment, 1 µM (2S,2’R,3’R)-2-(2’,3’-
dicarboxycyclopropyl) glycine (DCG-IV) (Tocris Bioscience) was added, and 
blockade ≥ 80% were taken to be MF inputs. Field potential slopes were measured, 
and data are expressed as mean ± standard error of mean. 
Subsection 4 Whole-cell recording of evoked AMPAR-mediated 
excitatory postsynaptic currents (EPSCs) 
The slices were visualized by an upright microscope (Nikon E600FN) 
equipped with infra-red oblique illumination. CA3 PCs and INTs located within the 
stratum lucidum of CA3 were initially identified on the basis of somata shape and 
position within the CA3 subfield, and patched by a whole-cell patch pipette (tip 
resistance, 3-5 MΩ) filled with the following (in mM): 120 CH3O3SCs, 5 MgCl2, 8 
NaCl, 1 EGTA, 10 HEPES, 1 QX-314, 0.5 Na3GTP, and 2 MgATP (pH 7.2-7.3, 280-
290 mOsm) in presence of 20 μM bicuculline, and 100 μM D,L-APV in the ACSF to 
isolate AMPAR-mediated EPSCs. Biocytin (Sigma-Aldrich, 1mg/ml) was routinely 
added to the recording electrode solution to allow post hoc morphological processing 
of the recorded cells. Recordings were made at 30°C at a holding potential of -70 mV. 
Additionally, 150 nM CNQX (Tocris Bioscience) was added to prevent polysynaptic 
responses for evoked EPSC in CA3 PCs. For evoked EPSC in INTs, CNQX was not 
used, as INTs were reported to show less recurrent excitation (Toth et al., 2000). A 
double-barrel glass electrode filled with ACSF as stimulation electrode was placed in 
the dentate granule cell layer to activate the MF inputs. Minimum-intensity 




IV was applied at the end of the recordings to verify that the currents were elicited by 
MF inputs. 20-30 waveforms were used to produce the average evoked EPSCs, and 
the amplitude was calculated by Igor Pro software (WaveMetrics). PPF was measured 
at 50 ms ISI. Only the cells and recording conditions that met the following criteria 
were studied: no obvious multiple EPSCs or polysynaptic waveforms, Rinput ≥ 125 
MΩ and Rseries ≤ 25 MΩ, and Rinput or Rseries changed less than 15% during the course 
of the experiment. 
Subsection 5 Whole-cell recording of miniature AMPAR-mediated 
EPSCs (mEPSCs) 
To record AMPAR-mediated mEPSCs, the same intracellular solution as 
evoked EPSCs was used in the recording pipette, 1 μM TTX (Tocris Bioscience), 20 
μM bicuculline (Enzo Life Science) and 100 μM DL-APV were added to the ACSF 
(29.5°C–30.5°C, 2 ml/min). mEPSCs were recorded at a holding potential of -70mV 
in CA3 PCs or INTs using an Axopatch 700B amplifier (Molecular Devices), 
digitized at 10 kHz by a data acquisition board (National Instruments), and acquired 
using a custom-made Igor Pro software (WaveMetrics). Acquired mEPSCs were 
analyzed using the Mini Analysis program (Synaptosoft). The threshold for detecting 
mEPSCs was set at three times the root mean square (RMS) noise. mEPSCs with > 3 
ms rise time (measured between 10 and 90% of amplitude) were excluded from 
analysis. Average mEPSC amplitude and frequency were calculated and compared 
between two genotypes using unpaired Student’s t test as noted in text. Only the cells 
with Rinput > 200 MΩ and Rseries < 25 MΩ were studied, cells were discarded if Rinput 




Subsection 6 Whole-cell recording of evoked GABAAR-mediated 
inhibitory postsynaptic currents (IPSCs) 
To record evoked GABAAR currents, 10 μM NBQX (Sigma-Aldrich) and 100 
μM DL-APV were added to isolate GABAAR component. Evoked IPSCs were 
recorded at 30°C at a holding potential of -70 mV in CA3 PCs with recording pipette 
filled with (in mM): 140 CsCl, 0.2 CaCl2, 8 NaCl, 2 EGTA, 10 HEPES, 0.5 Na3GTP, 
and 4 MgATP (pH 7.2, 275-285 mOsm). A double-barrel glass electrode filled with 
ACSF as stimulation electrode was placed in the stratum lucidum of CA3 where cell 
bodies of INTs are located. Minimum-intensity stimulation (15–30 μA intensity) was 
used to induce monosynaptic response. 20-30 waveforms were used to generate the 
average evoked EPCSs, and the amplitude was calculated by Igor Pro software 
(WaveMetrics). PPF was measured at 50, 100, 400 and 1000ms ISIs. Only cells with 
no obvious multiple EPSCs or polysynaptic waveforms, Rinput ≥ 125MΩ and Rseries 
≤ 25 MΩ, as well as cells showing less than 15% change in Rinput or Rseries during the 
course of the experiment, were included in the analyses. 
Subsection 7 Whole-cell recording of miniature GABAAR-mediated 
IPSCs (mIPSCs) 
For mIPSCs in CA3 PCs, the recording pipette was filled with (in mM): 140 
CsCl, 8 KCl, 10 EGTA, 10 HEPES, and 10 QX-314 (pH 7.3, 275-285 mOsm) in the 
presence of 1 μM TTX, 100 μM D,L-APV, and 10 μM NBQX in the ACSF to isolate 
GABAR-mediated currents. mIPSCs were recorded at a holding potential of -70mV 
and analyzed with the Mini Analysis program (Synaptosoft). The threshold for 




time (measured between 10 and 90% of amplitude) were excluded from analysis. 350 
to 500 consecutive events from each experiment were considered for the 
determination of mIPSC frequency, but highly superimposed events constituting 
“bursts” (more than two events, interevent interval < 10 ms) were excluded from the 
measurement of amplitudes (300 non-burst events from each cell were used for 
average mIPSC amplitude calculations). The decay time constant was calculated 
using the average of 150–200 well-isolated events. 
 
Section 3 Results 
Subsection 1 Younger BACE1 KOs show similar synaptic dysfunctions at 
mossy fiber to CA3 synapses as adults 
In the Chapter 2, we found that 3-6 month old BACE1 KOs display severe 
deficits in presynaptic function at mossy fiber synapses in CA3 including a reduction 
in presynaptic release and an absence of mossy fiber LTP. In order to use young 
BACE1 KOs for whole-cell recordings, we need to first verify that similar synaptic 
deficits at CA3 area can be detected at this age. Therefore, we performed extracellular 
field potential recording at mossy fiber to CA3 pathway of hippocampus in 3-week 
old BACE1 WT and KO mice. We measured presynaptic function by comparing 
paired-pulse facilitation (PPF) ratio at various interstimulus intervals (ISIs). Similar 
to results from older animals we found that young BACE1 KOs displayed 
significantly larger PPF ratios at shorter ISIs (25 ms ISI: WT = 3.4 ± 0.24; KO = 6.0 
± 0.44; 50 ms ISI: WT = 3.5 ± 0.23, n = 8 slices/4 mice; KO = 5.6 ± 0.49, n = 8 







Figure 3.1. Abnormal 
synaptic function at MF to 
CA3 synapses in young 
BACE1 KOs.  
A. Young BACE1 KOs (black 
circles) displayed larger PPF 
ratio (especially at 25 and 50 
msec ISIs) compared to WTs 
(white circles), which indicates 
a reduction in presynaptic 
release. Top panel: 
Representative field potential 
traces following paired-pulse 
stimulation at 50 msec ISI. 
*ANOVA: P < 0.001; Fisher’s 
PLSD post hoc test: P < 0.001 
between the two genotypes. 
B. Absence of mossy fiber 
LTP in young BACE1 KOs. 
Left: Summary graph plotting 
changes in normalized field 
potential against time. The 
arrow depicts when HFS (100 
Hz, 1 sec x 3) was delivered. 
Note that KOs (black circles) 
showed no LTP 60 minutes 
after LTP induction compared 
to WTs (white circles). Right: 
Superimposed representative 
field potential traces taken 
from WTs and KOs at times 
indicated in the left panel. 
50 ms ISI between WT and KO; data from slices were used for statistical analysis, see 






Next we compared mossy fiber LTP induced by high frequency stimulation 
(HFS: 3 x 100 Hz, 1 sec) from 3-week old BACE1 WT and KO mice. Again similar 
to our previous data from adults, we found that young BACE1 KOs display a larger 
initial potentiation, suggesting an enhanced facilitation during HFS, however, the 
responses returned to baseline by 1 hour (WT: 146 ± 5% of baseline at 1 hour post-
HFS, n = 8 slices/4 mice; KO: 106 ± 4%, n = 8 slices/4 mice; t-test: P < 0.001; Fig. 
3.1B). Consistent with a presynaptic locus of expression, LTP in WTs was 
accompanied by a decrease in PPF ratio measured at 50 ms ISI (baseline = 3.4 ± 0.26, 
1 hour post-HFS = 2.6 ± 0.20, n = 8 slices/4 mice, paired t-test: P < 0.001), but KOs 
displayed no change in PPF ratio (baseline = 5.4 ± 0.54, 1 hour post-HFS = 5.5 ± 0.56, 
n = 8 slices/4 mice, paired t-test: P = 0.54).  
These results suggest that 3-week old BACE1 KOs display both presynaptic 
release decrease and mossy fiber LTP abolishment at CA3 area of hippocampus 
similar to adults. Therefore, animal at this age were used in subsequent whole-cell 
patch-clamp recording experiments. 
Subsection 2 Reduced presynaptic function at MF to CA3 PC synapses in 
BACE1KOs 
The first set of synapses we examined in the CA3 circuit was the excitatory 
monosynaptic MF inputs to CA3 PCs. We stimulated dentate gyrus granule cell layer 
(Langdon et al., 1993) and performed whole-cell patch-clamp recordings from CA3 
PCs in CA3 pyramidal cell layer. Monosynaptic AMPAR-mediated EPSCs were 
isolated pharmacologically by applying APV, which is an antagonist of NMDARs, 




time of the evoked EPSC traces were analyzed, and there were no differences of these 
properties between the two genotypes (t test: P > 0.6 for each property; Table 3.1). 
We calculated PPF ratio as a measure of presynaptic function. Consistent with our 
previous extracellular field potential recording findings, BACE1 KOs displayed 
dramatic increase in PPF ratio at 50 ms ISIs compared to WT mice (WT = 3.1 ± 0.28, 
n = 11; KO = 5.4 ± 0.61, n = 10; t test: P < 0.01; Fig. 3.2C), suggesting a decrease in 
presynaptic function. To verify that the responses were elicited from MF inputs, 1 µM 
DCG-IV was bath applied at the end of the recording, which produced a comparable 
reduction in basal synaptic transmission in both genotypes (WT: 20.3 ± 3.7% of 
baseline, n = 11; KO: 17.6 ± 3.6%, n = 10; Fig. 3.2D). 
We next examined miniature EPSCs (mEPSCs) from CA3 PCs and compared 
the frequency and amplitude of the recorded mEPSCs between the two genotypes. 
BACE1 KOs showed a significant reduction in frequency (WT = 1.4 ± 0.3 Hz, n = 19; 
KO = 0.6 ± 0.1 Hz, n = 19; t test: P < 0.01; Fig. 3.3B), without changes in mEPSC 
amplitude distribution (the cumulative probability curve of mEPSC amplitude from 
KO and WT were overlapped, Kolmogorov-Smirnov test: P > 0.5; Fig. 3.3C) or the 
average mEPSC amplitude (WT = 19.4 ± 1.0 pA, n = 19; KO = 17.5 ± 1.4 pA, n = 19; 
t test: P = 0.28; Fig. 3.3C inset). These results are consistent with PPF ratio changes 
indicating presynaptic alteration. Together, these findings suggest that there is a 






Figure 3.2. Reduced presynaptic release at MF to CA3 PC monosynapses in 
BACE1 KOs. 
A. A sketch showing MF terminals onto PCs monosynapses within CA3 circuit. 
B. Representative evoked EPSCs traces from CA3 PCs following paired-pulse 
stimulation at 50 msec ISI before and after DCG-IV application in WTs and KOs. 
C. PPF ratio was significantly increased in BACE1 KOs (black bar) at 50 msec ISI 
compared to WTs (white bar). *t test: P < 0.01. 
D. Application of 1 µM DCG-IV reduced eEPSCs from CA3 PCs elicited by 
mossy fiber inputs in both WTs (white bar) and KOs (black bar). 
 
Table 3.1. ePSC properties 






Decay time    
(τ, ms) 
PCs eEPSCs WT n = 11 2.4 ± 0.1 1.8 ± 0.1 7.7 ± 0.5 
 KO n = 10 2.5 ± 0.1  1.9 ± 0.2 7.9 ± 0.6 
INTs eEPSCs WT n = 8 2.4 ± 0.1 1.1 ± 0.1 3.1 ± 0.3 
 KO n = 5 2.3 ± 0.2 1.0 ± 0.1 3.0 ± 0.2 
PCs eIPSCs WT n = 11 1.5 ± 0.1 2.3 ± 0.2 20.6 ± 1.9 







Figure 3.3. Altered mEPSCs from CA3 PCs in BACE1 KOs. 
A. Representative miniature EPSCs traces from CA3 PCs in WTs and KOs. 
B. BACE1 KOs (black bar) showed significantly decreased mEPSCs frequency in 
CA3 PCs compared to WTs (white bar). *t test: P < 0.01. 
C. Amplitude of mEPSCs in CA3 PCs was not altered in KOs. Left: The 
cumulative probability curve of KO mEPSC amplitudes (black solid line) 
superimposed with that of WT (gray solid line) (K–S test, P > 0.5). Inset: Average 
of mEPSC amplitude from CA3 PCs showed no change between the two groups 










Subsection 3 Normal synaptic function at MF to CA3 INT synapses in 
BACE1KOs 
The granule cell axons (MFs) have more than one terminal type including 
large complex mossy boutons, small en passant terminals, and small filopodial 
extensions of the mossy fiber boutons. MFs only innervate PCs via the large complex 
mossy boutons, whereas either small en passant or filopodial terminals preferentially 
target the stratum lucidum INTs (Chicurel and Harris, 1992; Acsady et al., 1998). To 
assess whether the MF synapses onto INTs in the stratum lucidum are altered in 
BACE1 KOs, we isolated excitatory MF inputs on INTs and recorded evoked EPSCs. 
The latency, rise time and decay time of the evoked EPSC traces were analyzed, and 
there were no differences of these properties between the two genotypes (t test: P > 
0.5 for each property; Table 3.1). In addition, there was no change in the PPF ratio 
between the two genotypes (WT = 1.8 ± 0.29, n = 8; KO = 1.7 ± 0.16, n = 5; t test: P 
= 0.84; Fig. 3.4C) suggesting that presynaptic function is not affected at this synapse. 
Bath application of 1 µM DCG-IV at the end of the recording resulted in a significant 
reduction in basal synaptic transmission in WTs and KOs (WT: 13.4 ± 5.5% of 
baseline, n = 8; KO: 12.7 ± 6.4%, n = 5; Fig. 3.4D), which confirmed that we were 
recording MF mediated synaptic responses. 
In addition to the evoked EPSCs, we examined mEPSCs from CA3 INTs and 
compared the frequency and amplitude between the two genotypes. We did not 
observe a significant change in the frequency (WT = 4.8 ± 0.7 Hz, n = 19; KO = 4.4 ± 
0.7 Hz, n = 14; t test: P = 0.69; Fig. 3.5B) or the amplitude of mEPSCs (the 






Figure 3.4. No change has been detected at MF onto CA3 INT synapses in 
BACE1 KOs. 
A. A sketch showing the synapses of MF terminals onto inhibitory neurons within 
stratum lucidum. 
B. Representative evoked EPSCs traces from CA3 INTs following paired-pulse 
stimulation at 50 msec ISI before and after DCG-IV application in WTs and KOs.
C. PPF ratio was not changed between the two genotypes (WT: white bar, KO: 
black bar) at 50 msec ISI. 
D. Application of 1 µM DCG-IV reduced eEPSCs from CA3 INTs elicited by 
mossy fiber inputs in both WTs (white bar) and KOs (black bar). 
overlapped, Kolmogorov-Smirnov test: P = 0.2; Average: WT = 22.5 ± 2.0 pA, n = 
19; KO = 22.0 ± 2.2 pA, n = 14; t test: P = 0.88; Fig. 3.5C). These results suggest that 
there is no change in pre- or postsynaptic function at MF to INT synapses of BACE1 
KOs.  
These observations indicate that only MF synapses onto CA3 PCs are 
impaired, while the same afferent inputs projecting onto INTs are normal in BACE1 







Figure 3.5. No change in mEPSCs from CA3 INTs between BACE1 WTs 
and KOs. 
A. Representative miniature EPSCs traces from CA3 INTs in WTs and KOs. 
B. There was no change in frequency of mEPSCs from CA3 INTs (WT: white 
bar, KO: black bar). 
C. Amplitude of mEPSCs in CA3 INTs was not altered in KOs. Left: The 
cumulative probability curve of KO mEPSC amplitudes (black solid line) 
superimposed with that of WT (gray solid line) (K–S test, P = 0.2). Inset: 
Average of mEPSC amplitude from CA3 INTs showed no change between the 
two groups (WT: white bar, KO: black bar). Right: Average mEPSC traces from 









Subsection 4 Reduced presynaptic function at CA3 INT to PC inhibitory 
synapses in BACE1KOs 
We have demonstrated that BACE1 can regulate excitatory synaptic 
transmission, which is postsynaptic target specific. However, whether BACE1 plays a 
role in modulating inhibitory synapses is unknown. We therefore investigated 
inhibitory inputs from CA3 INTs onto PCs in BACE1 KOs by isolating GABAAR-
mediated IPSCs within CA3 area using AMPAR antagonist NBQX and NMDAR 
antagonist APV. Stratum lucidum of CA3 were stimulated where INT cell bodies are 
located and recordings were made from CA3 PCs in CA3 pyramidal cell layer. We 
measured evoked IPSCs at a negative holding potential of -70mV using a 
symmetrical chloride internal solution that reverses IPSCs at 0 mV, and confirmed 
the isolation of IPSCs by showing a complete and reversible block of current by 
application of bicuculline (Fig. 3.6B). The latency, rise time and decay time of the 
evoked IPSC traces were analyzed, and there were no differences of these properties 
between the two genotypes (t test: P > 0.4 for each property; Table 3.1). Consistent 
with the high release probability at inhibitory synapses (Jiang et al., 2010), BACE1 
WT mice showed large paired-pulse depression (PPD) especially at shorter ISIs (PPD 
ratio: 50 ms ISI = 0.59 ± 0.04, n = 11; Fig. 3.6C). Surprisingly, the PPD was 
significantly impaired in BACE1 KOs (PPD ratio: 50 ms ISI = 0.92 ± 0.08, n = 12; 
ANOVA: P < 0.001; Fisher’s PLSD post hoc test: P < 0.001 for 50 ms ISI between 
WTs and KOs; Fig. 3.6C). The reduction in PPD seen in KOs suggests that there is a 
decrease in presynaptic function at these synapses. To our knowledge, it is the first 






Figure 3.6. Reduced presynaptic function at INT to CA3 PC inhibitory 
synapses in BACE1 KOs. 
A. A diagram showing the inhibitory projections from CA3 INTs to PCs. 
B. Left: Verification that the internal solution we used reversed mIPSCs at 0 mV. 
Each evoked IPSCs trace was recorded under different holding voltage as 
indicated. Right: The pharmacologically isolated eIPSCs were blocked by addition 
of 20 μM bicuculline (+Bic), and the currents were reversible when bicuculline 
was washed out. 
C. Paired-pulse depression was impaired in BACE1 KOs (black circles) especially 
at 50 msec ISI compared to WTs (white circles). Top panel: Representative 
evoked IPSCs traces from CA3 PCs following paired-pulse stimulation at 50 msec 






In addition, we compared mIPSCs from CA3 PCs across the two genotypes. 
Consistent with evoked IPSCs results showing a decrease in presynaptic function, 
BACE1 KOs displayed a significant reduction in frequency (WT = 18.6 ± 1.3 Hz, n = 
19; KO = 13.7 ± 1.3 Hz, n = 17; t test: P < 0.05; Fig. 3.7B), without changes in 
mIPSC amplitude distribution (The cumulative probability curve of mIPSC amplitude 
from KO and WT were overlapped, Kolmogorov-Smirnov test: P > 0.7; Fig. 3.7C) 
nor averaged mIPSC amplitude (WT = 42.2 ± 3.2 pA, n = 19; KO = 45.7 ± 3.6 pA, n 
= 17; t test: P = 0.46; Fig. 3.7C inset).  
These data suggest that in the CA3 circuit, BACE1 inhibition not only reduce 



















Figure 3.7. Reduced frequency of mIPSCs from CA3 PCs in BACE1 KOs. 
A. Representative miniature IPSCs traces from CA3 PCs in WTs and KOs. 
B. BACE1 KOs (black bar) showed significantly reduced mIPSCs frequency in 
CA3 PCs compared to WTs (white bar). *t test: P < 0.05. 
C. Amplitude of mIPSCs in CA3 PCs was not altered in KOs. Left: The 
cumulative probability curve of KO mIPSC amplitudes (black solid line) 
superimposed with that of WT (gray solid line) (K–S test, P > 0.7). Inset: Average 
of mIPSC amplitude from CA3 PCs showed no change between the two groups 











Section 4 Discussion 
This study indicates that within the CA3 circuit of hippocampus, presynaptic 
function of both excitatory inputs from MF and inhibitory inputs from INTs onto 
CA3 PCs are reduced in the BACE1 KOs. On the other hand, there was no change at 
excitatory projections from MF onto INTs. Our data, for the first time, suggest that 
BACE1 can regulate synaptic transmission of both excitatory and inhibitory 
component within the same neuronal circuit. The fact that the synapses affected by 
BACE1 inhibition are both targeted to CA3 PCs reveals that this effect is likely 
specified by the postsynaptic target independent of the type of inputs.  
Our finding that only synapses of MF inputs onto CA3 PCs, but not MF 
projections onto INTs, were altered by BACE1 inhibition is very intriguing. This 
further strengthens the idea that even though these two sets of synapses have common 
inputs, the functional characteristic of these two sets of synapses is quite different. 
Previous studies have shown that MF synapses onto CA3 PCs display distinct high 
level of facilitation indicative of low release probability (Nicoll and Schmitz, 2005); 
while MF synapses to INTs exhibit a higher probability of release and display either 
facilitation or depression by brief trains of stimulation (Toth et al., 2000). Recently, it 
has been found that different types of AMPARs are present at the two sets of 
synapses. MF inputs onto CA3 PC synapses contain only calcium-impermeable (CI) 
AMPARs (Toth et al., 2000); whereas MF inputs onto CA3 INT synapses contain 
both calcium-impermeable (CI) and calcium-permeable (CP) AMPARs (Toth and 
McBain, 1998). Interestingly, high frequency stimulation (100 Hz), which induces 




CI-AMPAR synapses (Lei and McBain, 2002), and NMDAR independent LTD at 
CP-AMPARs containing synapses on interneurons (Toth et al., 2000). Our results add 
to these differences and suggest that BACE1 function is more critical for maintaining 
normal synaptic transmission at the MF to CA3 PC synapses.  
Our study, for the first time, provides evidence that inhibiting BACE1 not 
only affected excitatory inputs, but also impaired feedforward inhibition of the CA3 
circuit. When interneurons and principal cells receive the same excitatory input, the 
inhibitory projections from interneurons onto principal cells form disynaptic 
feedforward inhibition (Buzsaki, 1984), which inhibits the excitability and tunes the 
firing pattern of the principal cells. Feedforward inhibition is one of the major 
components within neuronal circuits in many brain areas, such as hippocampal 
formation, visual cortex, sensory cortex, etc. (Buzsaki, 1984; Swadlow, 2003; 
Callaway, 2004), and plays a crucial role in circuit development as well as balancing 
excitation and inhibition to maintain neural activity (Chittajallu and Isaac, 2010). In 
the CA3 area of hippocampus, MF terminals innervating PCs are large with multiple 
release sites; whereas INTs receive small MF branches but large number of synapses. 
In addition, a single MF targets tens of inhibitory neurons, and each inhibitory 
interneuron can contact hundreds of CA3 PCs. This anatomy allows the CA3 circuit 
to form a high frequency filter, which permits high frequency responses to pass but 
low frequency responses are dampened by feedforward inhibition (Lawrence and 
McBain, 2003). If inhibitory synaptic transmission is damaged by blocking BACE1 




The evidence that both of the synapses modified by blocking BACE1 activity 
are synapsing onto CA3 PCs suggests that BACE1 in the postsynaptic PCs may 
actually plays an important role, and may bring about target specific regulation of 
synaptic transmission. However, it is still unknown how BACE1 at postsynaptic site 
would modulate presynaptic function. One potential candidate is Aβ generated by 
BACE1 processing of APP. Aβ, which can be secreted into synaptic cleft, may at as a 
retrograde signal from postsynaptic to presynaptic terminals to modify presynaptic 
function. In support of this, Aβ is implicated in presynaptic modifications by 
affecting presynaptic P/Q type Ca2+ channels and critical synaptic vesicle endocytosis 
protein dynamin (Kelly et al., 2005; Kelly and Ferreira, 2007; Nimmrich et al., 2008). 
Although from those studies, Aβ suppresses synaptic transmission, hence it seems 
counterintuitive that abolishing Aβ production, as in BACE1 KO mice, would reduce 
presynaptic function. However, we need to consider the fact that physiological 
concentration of Aβ (pM range) facilitates synaptic plasticity (Puzzo et al., 2008), and 
in this context the absence of Aβ in BACE1 KO mice is expected to produce synaptic 
deficits. 
Another possibility is that the presynaptic effects of BACE1 KOs may be from 
abnormal processing of neuregulin-1 (NRG1), a substrate of BACE1 (Hu et al., 2006; 
Willem et al., 2006), which affects presynaptic release by regulating the surface 
expression of presynaptic Ca2+ permeable α7-nAchRs (Seguela et al., 1993; Liu et al., 
2001b; Zhong et al., 2008). Presynaptic nAChRs can increase glutamate release 
(McGehee et al., 1995; Gray et al., 1996; Maggi et al., 2003b), likely via the α7 




can rescue the presynaptic deficits seen at MF to CA3 pathway in BACE1 KOs will 
be discussed in the next chapter. 
By isolating excitation and inhibition within the same neuronal circuit, we 
demonstrated that the absence of BACE1 produces presynaptic dysfunction at both 
excitatory and inhibitory components on CA3 PCs. Although reduction of presynaptic 
function at both types of synapses may be a compensation mechanism to keep the 
balance of excitation and inhibition, these changes likely impact synaptic function in 
the CA3 area of hippocampus as seen by an abolishment of mossy fiber LTP (Wang 
et al., 2008). The current study reveals BACE1 function at a circuit level, and may 
provide useful mechanistic information to circumvent the negative side effects caused 
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Section 1 Introduction 
Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), the neuronal 
β-secretase responsible for producing β-amyloid (Aβ) peptides, emerged as one of the 
key therapeutic targets of Alzheimer’s disease (AD) (Vassar, 2002; Citron, 2004b, a; 
Vassar et al., 2009). Although complete ablation of the BACE1 gene prevents Aβ 
formation (Cai et al., 2001), in the previous two chapters, we have shown that 
BACE1 KOs display severe presynaptic dysfunctions (Wang et al., 2008). The 
deficits include a reduction in presynaptic release at mossy fiber to CA3 synapses and 
an absence of mossy fiber long-term potentiation (mfLTP), which are due to 
abnormal presynaptic Ca2+ signaling (Wang et al., 2008). These studies caution the 
use of BACE1 inhibitors as a practical treatment for AD.  
Cholinergic system modulates neurotransmitter release from glutamatergic 
and GABAergic terminals via the action of nicotinic acetylcholine receptors (nAChRs) 
(Gray et al., 1996; Radcliffe et al., 1999; Giocomo and Hasselmo, 2005; Jiang and 
Role, 2008; Bancila et al., 2009). Among them, α7-nAChR is a Ca2+-permeable 




cortex (Seguela et al., 1993). Several studies have linked α7-nAChR with 
neurodegenerative disorders, including AD (Perry et al., 2000). In this chapter, we 
present data that activating α7-nAChRs, by nicotine or a specific agonist PNU282987, 
can restore presynaptic function at mossy fiber to CA3 synapses and mfLTP in 
BACE1 KOs via recruiting Ca2+-induced Ca2+ release (CICR). 
 
Section 2 Methods and Materials 
Subsection 1 Animals 
All mice used (BACE1 +/+ and –/–) were derived from heterozygous breeders 
(+/–) as described previously (Laird et al., 2005). The Institutional Animal Care and 
Use Committees of both University of Maryland and Johns Hopkins University 
approved all procedures involving animals. 
Subsection 2 Acute hippocampus slices preparation for electrophysiology 
Hippocampal slices were prepared from adult (3-6 months old) male BACE1 
knock-out or wild-type mice as described previously (Laird et al., 2005). Briefly, 
under deep anesthesia by isoflurane, mice were killed by decapitation, and their 
brains were removed quickly and transferred to the ice-cold dissection buffer  
containing the following (in mM): 212.7 sucrose, 2.6 KCl, 1.23 NaH2PO4, 26 
NaHCO3, 10 dextrose, 3 MgCl2, and 1 CaCl2  (bubbled with a mixture of 5% CO2 and 
95% O2). A block of hippocampus was removed and sectioned into 400 µm-thick 




artificial CSF (ACSF) (in mM): 124 NaCl, 5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 
dextrose, 1.5 MgCl2, and 2.5 CaCl2 (bubbled with a mixture of 5% CO2 and 95% O2). 
Subsection 3 Electrophysiological Recordings 
Recordings were done in a submersion-type recording chamber perfused with 
ACSF (saturated with 5% CO2/95% O2; 29.5°C–30.5°C, 2 ml/min). Synaptic 
responses were evoked through glass bipolar stimulating electrodes placed in the 
dentate granule cell layer to activate MFs with pulse duration of 0.2 ms (at 0.067 Hz), 
and recorded extracellularly in the stratum lucidum of CA3. PPF was measured at 25, 
50, 100, 200, 400, 1000, and 2000 ms ISIs. To induce mfLTP, three trains of 100 Hz 
(1 sec) stimuli were given at 20 sec intervals. We used α7-nAChR agonists (-)-
Nicotine (Sigma-Aldrich) and PNU282987 (Tocris Bioscience), and an antagonist α-
bungarotoxin (Tocris Bioscience). To block intracellular Ca2+ release, ruthenium red 
(Tocris Bioscience) or ryanodine (Tocris Bioscience) was applied. All experiments 
were done in the presence of 100 µM D,L-2-amino-5-phosphonovaleric acid (D,L-
APV) (Sigma-Aldrich) to isolate the presynaptic NMDAR-independent mfLTP 
(Nicoll and Schmitz, 2005). At the end of each experiment, 1 µM (2S,2’R,3’R)-2-
(2’,3’-dicarboxycyclopropyl) glycine (DCG-IV) (Tocris Bioscience) was added, and 
blockade ≥ 80% were taken to be MF inputs. Field potential slopes were measured, 
and data are expressed as mean ± standard error of mean. 
Subsection 4 Immunohistochemistry and confocal imaging 
Hippocampal slices (300-µm-thick) prepared from transgenic mice expressing 




Laboratory) were placed in 4% paraformaldehyde overnight (4°C) and transferred to 
30% sucrose [in 0.1 M sodium phosphate (SP) buffer] overnight before re-sectioning 
to 20 μm thickness using a freezing sliding microtome (Leica). The sections were 
collected in cryoprotectant (20% sucrose, 30% ethylene glycol in pH 7.4 SP buffer) 
and kept at -20°C. The day before primary antibody incubation, the sections were 
frozen at -80°C in 30% sucrose (in 0.1 M SP buffer). The following day, sections 
were defrosted and rinsed in PBS (4 5 min) and permeabilized [2% Triton X-100 
(TX-100) in SP buffer, 1 hour]. They were then incubated in -20°C methanol (10 
min), rinsed in PBS (4 5 min), and placed in 1% TX-100 blocking solution [10% 
normal donkey serum (NDS), 4% BSA in PBS] for 1 h at room temperature. Sections 
were then incubated in 0.2% TX-100 blocking solution with α7-nAChR antibody 
(1:500, rabbit polyclonal antibody, Abcam, Cambridge, MA) and synaptophysin 
antibody (1:20, mouse monoclonal antibody, Millipore, Billerica, MA) for 7 days at 
4°C. After washing (PBS, 4 5 min), sections were incubated for 2 h at room 
temperature in secondary antibodies [Alexa633 goat anti-rabbit IgG (1:500, 
Molecular Probes, Eugene, OR) and Alexa555 goat anti-mouse IgG (1:200, 
Molecular Probes, Eugene, OR)] in 1.5% NDS in PBS. Sections were rinsed in PBS, 
mounted on glass slides, and air-dried. The slides were coverslipped with ProlongTM 
mounting solution (Molecular Probes, Eugene, OR) and sealed with nail polish. The 
stained sections were imaged using a Leica SP5X confocal microscope with a 63 oil 
immersion objective lens. The CA3 subfield of the hippocampus was imaged through 




Subsection 5 Steady-state surface biotinylation 
Hippocampal slices (400 μm thick) were prepared as described above, and the 
CA3 region was isolated. After 30 min recovery at room temperature, the isolated 
CA3 slices were transferred to 30°C for additional 30 min recovery. The slices were 
then transferred to ice-cold ACSF for 10 min, and subsequently to ice-cold ACSF 
containing 2 mg/ml biotin (EZ-Link Sulfo-NHS-Biotin, Pierce) saturated with 5% 
CO2/95% O2 for 15 min. The slices were then washed in tris-buffered saline (TBS: 50 
mM Tris, 0.9% NaCl, pH 7.4) containing 100 mM glycine (5 times, 1 min each) 
before homogenized in ice-cold 0.2% SDS/1% Triton X-100 IPB (20 mM Na3PO4, 
150 mM NaCl, 10 mM EDTA, 10 mM EGTA, 10 mM Na4P2O7, 50 mM NaF, and 1 
mM Na3VO4, pH 7.4; with 1 µM okadaic acid and 10 KIU/ml aprotinin) by ~30 
gentle strokes using glass-teflon tissue homogenizers (Pyrex). The homogenates were 
centrifuged for 10 min at 13,200 × g, 4°C. Protein concentration of the supernatant 
was measured and normalized to 2 mg/ml. Some of the supernatants were saved as 
inputs by adding gel sampling buffer and boiled for 5 min. 300 µg of each 
supernatant was mixed with neutravidin slurry [1:1 in 1% Triton X-100 IPB (TX-
IPB)] and rotated overnight at 4°C. The neutravidin beads were isolated by brief 
centrifugation at 1,000 × g. Some of the supernatants were saved by adding gel 
sample buffer and boiled for 5 min. The neutravidin beads were washed 3 times with 
1% TX-IPB, 3 times with 1% TX-IPB containing 500 mM NaCl, followed by 2 
washes in 1% TX-IPB. The biotinylated surface proteins were then eluded from the 
neutravidin beads by boiling in gel sampling buffer for 5 min. The input (I, total 




surface fraction) were run on the same gel, and processed for immunoblot analysis 
using α7-nAchR and actin antibodies. The band intensity in the input lanes and biotin 
lanes, which fell within the linear range, was quantified to calculate the % of total α7-
nAchR on the surface for each sample. 
Subsection 6 Immunoblot analysis 
SDS-PAGE gels were transferred to polyvinyl difluoride (PVDF) membranes 
(ImmobilonTM, Millipore). The PVDF membrane blots were blocked for ~1 hr in 
blocking buffer (1% bovine serum albumin and 0.1% Tween-20 in phosphate 
buffered saline (PBS), pH 7.4), and subsequently incubated for 1-2 hrs in primary 
antibodies diluted in blocking buffer. After 5 x 5 min washes in blocking buffer, the 
blots were incubated for 1 hr in secondary antibodies linked to Cy3 and Cy5. After 
washes, blots were scanned using Typhoon Trio (GE Health), and signals were 
quantified using Image Quant TL software (GE Health). The fluorescence intensity 
values for each band was then normalized to the average value of WT samples on the 
same blot to obtain the % of average WT values, which were compared across 
different experimental groups using unpaired Student’s t-test. The biotinylation blots 
were also probed simultaneously with α7-nAchR and actin antibodies using the ECL 
plex system. The band intensities of biotinylated samples were normalized to that of 






Section 3 Results 
Subsection 1 Nicotine restores presynaptic function at MF to CA3 
synapses in BACE1 KOs 
We first examined the effect of nicotine on the presynaptic function of MF to 
CA3 synapses in BACE1 KOs by measuring paired-pulse facilitation (PPF). The 
results showed that nicotine decreased PPF ratio in a dose dependent manner at 25 
and 50 ms ISIs in KOs (n = 7 slices/3 mice; ANOVA: P < 0.05; Fig. 4.1A), and 10 
μM was the lowest concentration that significantly decreased PPF ratio in both 
genotypes (KO: control = 4.81 ± 0.16, nicotine = 4.05 ± 0.22, n = 15 slices/10 mice, 
paired t-test: P < 0.001; WT: control = 3.77 ± 0.43, nicotine = 3.50 ± 0.40, n = 10 
slices/9 mice, paired t-test: P < 0.001; Fig. 4.1B). We previously showed that BACE1 
KOs display a significant increase in PPF ratio at MF synapses indicating a reduction 
in presynaptic release (Wang et al., 2008). Nicotine at 10 μM concentration decreased 
the PPF ratio of KOs to a similar level of WTs (t-test: P = 0.57) without affecting 
synaptic transmission in either genotype (KO: 100 ± 1% of baseline at 20 min post-
nicotine, n = 15 slices/10 mice; paired t-test: P = 0.97; WT: 99 ± 1%, n = 10 slices/9 
mice; paired t-test: P = 0.54; Fig. 4.1B). These results suggest that 10 μM nicotine 
reverses PPF deficits in BACE1 KOs without affecting synaptic strength. Therefore, 










Figure 4.1. Nicotine recovers deficits in PPF at MF synapses in BACE1 KOs. 
A. Nicotine reduced PPF ratio in a dose-dependent manner, which was significant 
at 25 and 50 ms ISIs. *ANOVA, P < 0.05; Fisher’s PLSD, P < 0.05 between 
control and 10, 50, 100 µM nicotine groups. 
B. Nicotine (10 μM) significantly decreased PPF ratio in both genotypes, but did 
not influence basal synaptic transmission. Top: Representative FP traces of 
paired-pulse stimulation (50 ms ISI) before (thin traces) and after (thick traces) 
nicotine. Scale: KO 1 mV, WT 0.5 mV, 10 ms. Bottom left: No change in basal 
synaptic strength with nicotine (KO, black circles; WT, white circles). Bottom 
right: Comparison of PPF ratio (50 ms ISI) before (C) and after (N) nicotine 






Subsection 2 Nicotine rescues mfLTP in BACE1 KOs without affecting 
mfLTP in WTs 
Consistent with our previous results, KOs lacked mfLTP under control 
conditions, but 10 μM nicotine applied during the whole duration of the experiment 
restored mfLTP (control: 95 ± 4% at 1 hour post-HFS, n = 6 slices/4 mice; nicotine: 
133 ± 7%, n = 8 slices/7 mice; t-test: P < 0.001; Fig 4.2A). Nicotine-induced rescue 
of mfLTP was accompanied by a significant decrease in PPF ratio (50 ms ISI; 
baseline: 4.36 ± 0.26, 1 hour post-HFS: 3.01 ± 0.27, paired t-test: P < 0.001; Fig. 
4.2A inset) suggesting presynaptic expression. Interestingly, 10 μM nicotine did not 
alter the magnitude of mfLTP in WTs (control: 148 ± 3% at 1 hour post-HFS, n = 5 
slices/3 mice; nicotine: 144 ± 6%, n = 7 slices/6 mice; t-test: P = 0.52; Fig. 4.2B).  
To investigate whether nicotine affects the induction mechanisms of mfLTP, 
we transiently applied nicotine for 10 min before and during the HFS. KOs displayed 
significant mfLTP, which was similar in magnitude with that evoked in WTs (KO = 
147 ± 2% at 1 hour post-HFS, n = 8 slices/5 mice, paired t-test: P < 0.001; WT: 157 ± 
8%, n = 8 slices/5 mice, paired t-test: P < 0.001; Fig. 4.2C, D). Furthermore, mfLTP 
was accompanied by a significant decrease in PPF ratio (50 ms ISI) in both genotypes 
(WT: baseline = 3.66 ± 0.16, 1 hour post-HFS = 2.55 ± 0.21, paired t-test: P < 0.001; 
KO: baseline = 4.59 ± 0.35, 1 hour post-HFS = 2.95 ± 0.33, paired t-test: P < 0.001; 
Fig. 4.2C, D insets), consistent with an increase in presynaptic release. These results 







Figure 4.2. Nicotine rescues mfLTP in BACE1 KOs without effects in WTs. 
A. KO slices treated with 10 μM nicotine (black circles) showed significant 
mfLTP compared to control slices without nicotine (white circles).  
B. The magnitude of mfLTP in WT slices treated with 10 μM nicotine (black 
squares) was similar to that of control WT slices (white squares).  
C. Transient application of nicotine (10 μM, 10 min; gray bar) before and during 
HFS rescued mfLTP in KOs (black circles).  
D. The same transient nicotine (10 μM, 10 min; gray bar) application did not 
influence mfLTP in WT (black squares).  
Insets: (A, B) Changes in PPF ratio with HFS [ΔPPF ratio = (PPF ratio at time 
b) – (PPF ratio time a)] for control (Ctl) and nicotine (Nic); (C, D) ΔPPF ratio 
with nicotine application [= (PPF ratio at time b) – (PPF ratio at time a)] and 
with HFS [= (PPF ratio at time c) – (PPF ratio at time a)]. Bars: average ± sem. 
Open circles: individual data points. *paired t-test, P < 0.001. 
Arrow: HFS (100 Hz, 1s × 3). Right panels: Superimposed FP traces taken at 





Subsection 3 Nicotine-induced rescue of mfLTP in BACE1 KOs is 
mediated by α7-nAChRs 
We showed that presynaptic dysfunction of MF synapses in BACE1 KOs is at 
the level of Ca2+ regulation (Wang et al., 2008). To determine whether nicotine acts 
via the Ca2+-permeable α7-nAChRs, we used a specific agonist PNU282987 (Bodnar 
et al., 2005). A brief application of PNU282987 (500 nM, 10 min) before and during 
HFS recovered mfLTP in KOs (1 hour post-HFS: 167 ± 19%, n = 8 slices/5 mice; 
paired t-test: P < 0.05; Fig 4.3A). Furthermore, PPF ratio decreased significantly after 
PNU282987 application and further by LTP induction (baseline: 6.29 ± 0.77, 
+PNU282987: 5.81 ± 0.76, 1 hour post-HFS: 4.80 ± 0.69, Fig. 4.3A inset). 
PNU282987 alone did not produce changes in synaptic strength (1 hour post-
PNU282987: 105 ± 4%, n = 4 slices/2 mice; paired t-test: P = 0.30; Fig 4.3A).  
To further test whether nicotine-induced rescue of mfLTP was mediated by 
α7-nAChRs, we applied 100 nM α-bungarotoxin (αBTX), a selective antagonist. 
αBTX abolished the effect of nicotine on mfLTP (1 hour post-HFS: 105 ± 4%, n = 10 
slices/6 mice; paired t-test: P > 0.05; Fig 4.3B) and PPF ratio (αBTX: 5.22 ± 0.65, 
αBTX+nicotine: 5.17 ± 0.65, 1 hour post-HFS: 5.19 ± 0.73; Fig. 4.3B inset) in KOs. 
Application of αBTX and nicotine in the absence of HFS did not alter synaptic 
transmission (1 hour-post αBTX+Nic: 100 ± 1%, n = 4 slices/2 mice; paired t-test: P 
= 0.86; Fig 4.3B). These results suggest that nicotine-induced rescue of presynaptic 
deficits in BACE1 KOs is mediated by α7-nAChRs.  
Finally, we tested whether α7-nAChRs are required for mfLTP in WTs. A 




Figure 4.3. Nicotine-induced 
rescue of mfLTP in BACE1 KO is 
mediated by α7-nAChRs. 
A. Transient bath application of 
PNU282987 (PNU: 500 nM, 10 min; 
gray bar) rescued mfLTP in KOs 
(black circles). PNU282987 alone 
did not alter synaptic transmission 
(white circles). Inset: ΔPPF ratio in 
KO PNU+HFS experiments. ΔPPF 
ratio with PNU282987 application 
[= (PPF at b) – (PPF at a)]; ΔPPF 
ratio with HFS [= (PPF at c) – (PPF 
at a)], *paired t-test: P < 0.01. 
B. Application of αBTX (100 nM, 
black bar) blocked nicotine-induced 
rescue of mfLTP in KOs (black 
circles). Application of αBTX and 
nicotine without HFS did not 
influence basal synaptic 
transmission (white circles). Inset: 
ΔPPF ratio in KO αBTX+Nic+HFS 
experiments. ΔPPF ratio with 
nicotine application in the presence 
of αBTX [= (PPF at b) – (PPF at a)]; 
ΔPPF ratio with HFS [= (PPF at c) – 
(PPF at a)]. 
C. MfLTP in wildtype is not blocked 
by αBTX. αBTX alone (100 nM, 10 
min; gray bar) did not affect 
synaptic transmission (white 
squares). αBTX+HFS: black 
squares. Inset (for αBTX+HFS 
experiments): ΔPPF ratio with 
αBTX [= (PPF at b) – (PPF at a)]; 
ΔPPF ratio with HFS [= (PPF at c) – 
(PPF at a)]; *Paired t-test, P < 0.001. 
Right: FP traces. Scale: 0.5 mV, 5 
ms. 
WTs (1 hour post-HFS: 148 ± 6%, n = 9 slices/7 mice; paired t-test: P < 0.001; Fig. 
4.3C). This indicates that activation of α7-nAChRs is not necessary for mfLTP 
induction in WTs, hence the rescue of mfLTP in KOs by α7-nAChR activation is 




Subsection 4 Calcium-induced calcium release (CICR) is involved in 
nicotine-induced rescue of mfLTP in BACE1 KOs 
Activation of α7-nAChRs enhances CICR from ryanodine-sensitive Ca2+ 
stores (Sharma and Vijayaraghavan, 2003; Sharma et al., 2008). To investigate 
whether CICR is also involved in nicotine-induced rescue of mfLTP in KOs, we used 
20 μM ruthenium red (RR) or 100 μM ryanodine (Ryan), which are blockers of 
ryanodine-sensitive stores. Both drugs completely abolished nicotine-induced 
recovery of PPF ratio (RR: 5.00 ± 0.69, RR+Nic: 4.97 ± 0.70, 1 hour post-HFS: 4.62 
± 0.74, Fig. 4.4A inset; Ryan: 5.01 ± 0.20, Ryan+Nic: 5.03 ± 0.23, 1 hour post-HFS: 
4.93 ± 0.25) and mfLTP in KOs (1 hour-post RR+Nic: 91 ± 5%, n = 9 slices/5 mice; 
paired t-test: P = 0.18; 1 hour-post Ryan+Nic: 100 ± 2%, n = 6 slices/3 mice; paired t-
test: P = 0.66; Fig 4.4A) without influencing basal synaptic transmission. MfLTP was 
present in WTs treated with RR (1 hour-post HFS: 124 ± 5%, n = 9 slices/5 mice; 
paired t-test: P < 0.01; Fig 4.4B), but was significantly less than that in control WTs 













induced rescue of mfLTP 
in BACE1 KOs requires 
Ca2+ induced Ca2+ release 
(CICR). 
A. Application (black bar) 
of ruthenium red (RR, 20 
μM) or ryanodine (Ryan, 
100 μM) abolished 
nicotine-induced rescue of 
mfLTP in KOs (RR: black 
circles, Ryan: gray 
triangles). Inset: ΔPPF ratio 
of RR application [= (PPF 
at b) – (PPF at a)]; 
+nicotine [= (PPF at c) – 
(PPF at b)]; +HFS [= (PPF 
at d) – (PPF at b)]. 
B. RR (20 μM; black bar) 
reduced mfLTP in WTs 
(white squares). Inset: 
ΔPPF ratio of RR 
application [= (PPF at b) – 
(PPF at a)]; +HFS [= (PPF 
at c) – (PPF at b)], *paired 
t-test: P < 0.01. 
Right: FP traces. Scale: 0.5 












Section 4 Discussion 
We found that nicotine restores PPF and LTP at MF to CA3 synapses in 
BACE1 KOs. The nicotine effect was mimicked by α7-nAChR specific agonist 
PNU282987, and blocked by α7-nAChR antagonist αBTX. We have evidence that 
nicotine acts via recruiting CICR. These results suggest nicotine and α7-nAChR 
agonists as potential pharmacological means to circumvent the presynaptic deficits 
caused by BACE1 inhibition. 
MfLTP is presynaptically expressed requiring an increase in presynaptic Ca2+ 
and a subsequent activation of cAMP-PKA signaling pathway (Nicoll and Schmitz, 
2005). We previously demonstrated that presynaptic dysfunction seen in BACE1 KOs 
is at the level of Ca2+ regulation, but the downstream PKA signaling is intact (Wang 
et al., 2008). These results predict that restoring presynaptic Ca2+ signaling should 
recover mfLTP in BACE1 KOs. Presynaptic α7-nAChR elevates the intracellular 
concentration of free Ca2+ (Vijayaraghavan et al., 1992) and enhances glutamate 
release at MF terminals (Sharma and Vijayaraghavan, 2003; Sharma et al., 2008; 
Bancila et al., 2009). The nicotine-induced rescue of PPF and mfLTP without much 
effect on basal synaptic transmission is likely via the recruitment of CICR, which is 
known to preferentially amplify use-dependent release (Shimizu et al., 2008). Short-
term presynaptic plasticity, including PPF, does not depend on CICR at MF terminals 
(Carter et al., 2002). Consistent with this, inhibiting CICRs in WTs did not alter PPF 
ratio, but reduced mfLTP magnitude, which suggests that HFS recruits CICR. In the 
case of KOs, it is clear that the CICR triggered by α7-nAChR activation is needed to 






Figure 4.5. Immunohistochemical labeling of α7-nAChRs in the CA3 region 
of a YFP-2J mouse. 
Top left: YFP signal in a subset of CA3 neurons. Top right: α7-nAChR 
immunoreactivity (Alexa633-linked secondary antibody). Note a higher signal in 
the stratum lucidum. Bottom left: Synaptophysin immunoreactivity (Alexa555-
linked secondary antibody). Bottom right: Overlay of YFP (green), α7-nAChR 
(red), and synaptophysin (blue). Note purple signal in stratum lucidum, which 
indicates overlap of α7-nAChR and synaptophysin immunoreactivity. Scale: 40 
µm. 
on interneurons, the detection of α7-nAChR immunoreactivity in the MF input region 
(Fig 4.5) provides a substrate for α7-nAChR agonists to act on MF terminals. This is 
further corroborated by a recent electron microscopy study, which localized α7-
nAChRs on MF terminals (Bancila et al., 2009). Interestingly, the α7-nAChRs were 





It is known that α7-nAChRs can rapidly desensitize upon agonist binding in a 
dose-dependent manner (Peng et al., 1994). Because nicotine-induced rescue of 
mfLTP was blocked by αBTX, we suspect residual α7-nAChR activity even with the 
prolonged application of nicotine used in our study. Interestingly, the increase in 
glutamate release at MF terminals with α7-nAChR activation is rather slow and 
involves presynaptic Ca2+ increase via CICR from internal stores (Sharma and 
Vijayaraghavan, 2003; Sharma et al., 2008). In synaptosomes isolated from the 
prefrontal cortex, α7-nAChR agonist-induced glutamate release is dependent on 
CICR and a downstream activation of extracellular signal-regulated kinase (ERK) 
signaling (Dickinson et al., 2008). These results suggest that presynaptic signaling of 
α7-nAChRs leading to glutamate release may outlast the initial activation of the 
receptor. 
The regulation of α7-nAChRs has been implicated in the pathology of AD. 
There are studies reporting high affinity binding between Aβ42 and α7-nAChRs 
(Wang et al., 2000b; Wang et al., 2000a), which either inhibit (Guan et al., 2001; Liu 
et al., 2001a; Pettit et al., 2001) or activate α7-nAChR signaling (Dineley et al., 2001). 
It is possible that Aβ42 may facilitate α7-nAChRs at low concentration, but may 
inhibit nAChRs when the burden of Aβ peptides increases (Dineley et al., 2001; 
Dougherty et al., 2003). The concentration-dependent dual role of Aβ42 is evident in 
a study showing that picomolar range of Aβ42 facilitates, but nanomolar range 
abolishes, LTP in CA1 and learning via its action on α7-nAChRs (Puzzo et al., 2008). 
It is unlikely that endogenous Aβ42 acts in this manner to influence mfLTP, because 




argues that the lack of mfLTP in BACE1 KOs may not be a strict consequence of 
lacking Aβ. Interestingly, BACE1 has been found to regulate neuregulin-1 (NRG1) 
cleavage (Hu et al., 2006; Willem et al., 2006), and indeed this process is affected in 
BACE1 KOs (Savonenko et al., 2008). NRG1 is critically involved in maintaining 
surface expression of presynaptic α7-nAChRs (Hancock et al., 2008; Zhong et al., 
2008). However, in isolated CA3 slices, we did not see a change in the total or cell 
surface levels of α7-nAChRs and NRG1 in the KOs (Fig 4.6). Furthermore, our 
ability to rescue mfLTP in KOs with α7-nAChR agonists suggests sufficient presence 
of functional α7-nAChRs.  
Several potential methods are being developed to overcome dysfunctions 
caused by complete BACE1 inhibition, such as partial BACE1 inhibition (Vassar et 
al., 2009). While our results might reflect a developmental loss of BACE1, they 

















Figure 4.6. Normal expression of α7-nAChRs in the CA3 region of BACE1 
KOs. 
A. Comparison of α7-nAChR and neuregulin-1 (NRG1) levels in the total 
homogenates of isolated CA3 regions of WT and KOs. Left: An example 
immunoblots probed with α7-nAChR or NRG1 antibody. Right: Quantification of 
the immunoblots for total α7-nAChR (WT = 100 ± 5.7% of average WT value; 
KO = 92 ± 12.9% of average WT value; n = 10 mice each group; t-test: P > 0.58) 
and total NRG1 (WT = 100 ± 5.2% of average WT value; KO = 96 ± 14.6% of 
average WT value; n = 10 mice each group; t-test: P > 0.82).  
B. Comparison of cell surface α7-nAChR levels in isolated CA3 slices between 
WT and KO. Cell surface α7-nAChRs were isolated using steady-state surface 
biotinylation. The total protein (input, I), the resulting supernatant (S: intracellular 
protein fraction), and biotin pull-down (B: cell surface fraction) were loaded onto 
the same gel, transferred to blots, and simultaneously probed with α7-nAChR and 
actin antibodies using the ECLplex system (GE Health). The intensity of signals 
in the input and the biotin lanes was used to calculate the fraction of surface α7-
nAChRs as a % of total α7-nAChR. Actin signal was used to assess the success of 
the biotinylation assay. Only the blots showing less than 5% actin signal in the 
biotin lane was used for quantification. Left: An example immunoblot from WT 
and KO. Right: Quantification of biotinylated α7-nAChR signals (Surface α7-
nAChR: WT = 21 ± 1.0% of total, n = 10 mice; KO = 23 ± 1.7% of total, n = 8 






Chapter 5: General discussions and Future directions 
 
My thesis focused on the effect of inhibiting BACE1 on synaptic transmission and 
plasticity at synaptic loci where BACE1 is highly expressed in brain. In addition, I 
identified pharmacological means to circumvent the synaptic dysfunctions caused by 
BACE1 inhibition. In this chapter I will summarize the conclusions obtained from my 
studies, and discuss their significance and future directions. 
 
Section 1 Physiological function of BACE1 
From my study, the physiological function of BACE1 in both synaptic 
transmission and plasticity was characterized for the first time in the CA3 circuit of 
hippocampus by using BACE1 KO mice. At mossy fiber synapses on CA3 pyramidal 
neurons, BACE1 KO mice displayed severe deficits in presynaptic function including 
a reduction in presynaptic function and an absence of mossy fiber LTP, which is 
normally expressed by a long-term increase in presynaptic release (Weisskopf et al., 
1994). Moreover, BACE1 KO mice exhibited a slightly larger mossy fiber LTD, 
which could not be reversed. These results suggest that BACE1 function is crucial for 
normal synaptic transmission and activity-dependent presynaptic potentiation at these 
synapses. I further found evidence that the presynaptic dysfunction in BACE1 KO is 
likely at the level of presynaptic Ca2+ signaling, because the mossy fiber LTP deficit 
in BACE1 KO mice could be recovered by increasing the extracellular Ca2+ 
concentration. This suggests that the signaling downstream of Ca2+ is more or less 




presynaptic potentiation resulting from direct activation of the cAMP signaling 
pathway is normal in the BACE1 KO mice. The presynaptic deficits seen in BACE1 
KOs may be due to the absence of Aβ peptides. There is evidence that Aβ is involved 
in presynaptic modifications by affecting presynaptic P/Q type Ca2+ channels and 
critical synaptic vesicle endocytosis protein dynamin (Kelly et al., 2005; Kelly and 
Ferreira, 2007; Nimmrich et al., 2008), which indicate the possible role of Aβ in 
regulating preysnaptic Ca2+ and vesicle release. At first glance of these results, the 
evidence that Aβ reduces synaptic transmission, may contradict our findings, because 
the absence of Aβ as in BACE1 KOs is expected to increase presynaptic release. 
However, there is accumulating evidence that Aβ is a double-edged sword on 
regulating synaptic function (discussed in Chapter 1), where normal physiological 
concentration of Aβ (pM range) facilitates, but higher burden of Aβ peptides 
jeopardizes (Puzzo et al., 2008), synaptic function. Therefore, it is not surprising that 
the absence of Aβ in BACE1 KO mice may result in presynaptic deficits. 
Another possibility is that the presynaptic dysfunction of BACE1 KOs may be 
because of abnormal processing of neuregulin-1 (NRG1), a substrate of BACE1 (Hu 
et al., 2006; Willem et al., 2006), which affects presynaptic release by regulating the 
surface expression of presynaptic Ca2+ permeable α7-nAchRs (Seguela et al., 1993; 
Liu et al., 2001b; Zhong et al., 2008). Presynaptic nAChRs can increase glutamate 
release (McGehee et al., 1995; Gray et al., 1996; Maggi et al., 2003b), likely via the 
α7 containing nAChRs (Le Magueresse et al., 2006). Indeed, I have demonstrated that 
activation of α7-nAchRs by nicotine or α7-nAChRs agonist can restore presynaptic 




BACE1 KO mice. The cellular mechanism of nicotine-induced rescue is dependent 
on the recruitment of Ca2+ induced Ca2+ release from intracellular Ca2+ stores through 
ryanodine receptors after α7-nAchR activation. 
A third possibility is the augmented α-secretase activity in the BACE1 KOs. 
α-secretase and β-secretase have been shown to compete with each other to cleave 
APP (reviewed in (Turner et al., 2003)), hence in BACE1 KO mice APP tends to be 
processed through the non-amyloidogenic α-secretase pathway, consistent with the 
evidence that BACE1 KO mice have higher level of sAPPα, a product of the α-
secretase (Luo et al., 2001). sAPPα has been shown to reduce the resting intracellular 
Ca2+ level and regulate cell excitability (Mattson et al., 1993; Furukawa et al., 1996). 
Therefore, the increased sAPPα level in the BACE1 KOs may downregulate the 
presynaptic function via these processes. 
To examine the effect of BACE1 on an intact neuronal circuit, I expanded the 
analysis to CA3 circuit containing both excitatory and inhibitory synaptic 
transmission. I found that not only is the presynaptic release at mossy fiber synapses 
on CA3 pyramidal cells decreased, the presynaptic function at the inhibitory inputs on 
CA3 pyramidal neurons is also impaired in the BACE1 KOs. Interestingly, BACE1 
KOs do not exhibit significant dysfunction at the mossy fiber input to CA3 inhibitory 
interneurons. These results suggest that the role of BACE1 in regulating synaptic 
function is specifically dependent on the nature of the postsynaptic target. My 
observation that both excitatory and inhibitory inputs to CA3 pyramidal cells are 
influenced by BACE1 ablation indicates that BACE1 modulates synaptic integration 




pyramidal cells, but also has the potential to control the output of these neurons which 
relays information signals to CA1 region of hippocampus. The modification of 
input/output properties of CA3 neurons may be the cellular mechanisms of behavioral 
deficits seen in BACE1 KOs (Laird et al., 2005).  
 
Section 2 Nicotine and AD  
Subsection 1 The role of nicotine in modulating synaptic function and 
plasticity 
Nicotine has been found to regulate synaptic transmission in the brain, 
especially playing a prominent role in presynaptic modification of neurotransmitter 
release (for review, see (McGehee and Role, 1996; Wonnacott, 1997)). It has been 
clearly documented that nicotinic enhances dopaminergic transmission, which may be 
an important mechanism underlying the addictive properties of nicotine (for review, 
see (Stolerman and Shoaib, 1991; Dani and Heinemann, 1996)). Recently, nicotinic 
enhancement of glutamatergic transmission has been observed in several brain areas 
(McGehee et al., 1995; Alkondon et al., 1996; Guo et al., 1998), including the 
hippocampus (Gray et al., 1996) and neocortex (Vidal and Changeux, 1993). The 
mechanism underlying these involves interaction of nicotine with presynaptic 
nAChRs, especially α7-nAChRs. α7-nAChR has a pentameric structure, but differs 
from other neuronal nAChRs which are comprised of combination of α (α2-α6) and β 
(β2-β4) subunits, it contains five α7 subunits (Decker et al., 1995; Jones et al., 1999; 
McGehee, 1999; Hogg et al., 2003). The special property of this receptor is that it is 




α7-nAChR activation plays an important role in nicotine induced enhancement of 
glutamate release due to its ability to increase presynaptic Ca2+. Radcliffe et al. found 
that a brief nicotine application strongly increased presynaptic glutamate release in 
hippocampal cell culture as measured by a significant increase in mEPSCs frequency 
and reduction of PPF ratio. This effect was mediated by α7-nAChRs and required 
Ca2+ influx in presynaptic terminals (Radcliffe and Dani, 1998). At mossy fiber to 
CA3 pyramidal cell synapses, it has been reported that 20 μM nicotine can increase 
spontaneous release, which is accompanied by Ca2+ increase in response to α7-
nAChR activation in mossy fiber boutons very likely via recruiting Ca2+ induced Ca2+ 
release through ryanodine receptors (Sharma et al., 2008). This study as well as others 
suggests that although a7 nAChRs desensitize rapidly upon exposure to agonist 
(Castro and Albuquerque, 1993; Peng et al., 1994; Zhang et al., 1994), it may 
contribute to prolonged enhancement of presynaptic release by allowing increases in 
Ca2+ in the presynaptic terminals via triggering Ca2+ release from internal stores 
(Sharma and Vijayaraghavan, 2003; Dickinson et al., 2008; Sharma et al., 2008). In 
addition to regulating synaptic transmission, nicotine is also demonstrated to 
modulate synaptic plasticity. Numerous studies have been done to investigate the 
effect of nicotine on Schaffer collateral-CA1 LTP and perforant path-dentate gyrus 
LTP (reviewed in (Kenney and Gould, 2008)). However, whether nicotine can 
influence mossy fiber-CA3 LTP has not been shown before. I have found that 10 μM 
nicotine significantly increases glutamate release at mossy fiber synapses on CA3 
pyramidal cells in WTs and BACE1 KOs. Furthermore, nicotine, by activating α7-




BACE1 KOs with no influence on mossy fiber LTP in WTs. This finding is very 
promising because we expected to rescue the deficits in BACE1 KOs without 
introducing new side effects in the system. The fact that nicotine does not affect 
normal mossy fiber LTP in WTs is likely because preysnaptic Ca2+ signaling in 
response to high frequency stimulation in WTs is already saturated. And the evidence 
that inhibiting α7-nAChRs by α-bungarotoxin during mossy fiber LTP induction does 
not block LTP in WTs supports the idea that activation of α7-nAChRs is not normally 
required for LTP induction at these synapses. These results suggest that nicotine-
induced rescue of mossy fiber LTP in BACE1 KOs utilizes a bypass mechanism, 
which is not normally recruited in WT mice.  
Besides regulating glutamatergic transmission, nicotine has also been found to 
modulate GABAergic transmission. It has been reported that nicotine can increase 
inhibitory inputs to the principal cells of local circuits in both CNS and PNS 
(Radcliffe et al., 1999; Genzen and McGehee, 2005; McGehee, 2007), which involves 
presynaptic nAChRs activation on interneurons in a Ca2+-dependent manner 
(Radcliffe et al., 1999; Liu et al., 2007). Interestingly, in the CA1 circuit of 
hippocampus, activation of interneurons not only directly inhibits pyramidal neuron 
activity, but also produces inhibition of other GABAergic cells leading to 
disinhibition of pyramidal cells. Both the inhibition and disinhibition effects are 
mediated by α7-nAChRs (Ji and Dani, 2000; Buhler and Dunwiddie, 2002). The dual 
mechanism allows fine-tuned control of nicotine on inhibition within a neuronal 
circuit, which in turn modulates the input/output of the information flow. Although 




mossy fiber synapses in CA3 area, whether nicotine can also regulate inhibitory 
inputs in the circuit is unknown. Future studies will be necessary to verify whether 
nicotine has inhibition and/or disinhibition effects on the CA3 circuit, which may 
control the output from CA3 to CA1 area of hippocampus where many learning and 
memory formations are associated (Kenney and Gould, 2008). Besides, it is very 
interesting to know whether nicotine can also rescue the deficits in GABAergic 
terminals of CA3 interneurons caused by BACE1 inhibition, which will provide full 
evidence of the mechanism underlying nicotine induced rescue of the synaptic 
dysfunction, hence will allow better development of therapeutics that can overcome 
the negative effects of long-term BACE1 inhibition needed for AD treatment. 
Subsection 2 Nicotine therapy as a potential treatment for AD 
Another characteristic of AD is degeneration of the cholinergic neurons in the 
basal forebrain, reduction of cholinergic projections, and loss of nicotinic receptors in 
the cortex and hippocampus (Paterson and Nordberg, 2000; Auld et al., 2002). 
Therefore, nicotine and nicotinic receptor agonist application could be potential 
therapy for AD. The emerging evidences suggest that it may be the case. An in vivo 
study showed that nicotine treatment (2 mg/kg/day, 6 weeks) prevents CA1 LTP and 
LTD deficits in an AD mouse model (Alkadhi et al., 2011). Echeverria et al. found 
that cotinine, the main metabolite of nicotine, which does not have addictive side 
effects in humans, significantly decreased Aβ deposition, inhibited Aβ42 aggregation, 
and more impressively, improved working and reference memories in a transgenic 
AD mouse model (Echeverria et al., 2011). Although a lot of work still needs to be 




significant effect on AD. Indeed, α7-nAChR has become a drug target for many 
cognitive disorders including AD (reviewed in (Wallace and Porter, 2011; Russo et 
al., 2012)). In my study, I have shown that nicotine or α7-nAChR agonist can 
overcome presynaptic dysfunction and restore the abolished mossy fiber LTP due to 
blocking of BACE1. My results suggest that nicotine or α7-nAChR agonist 
application combining with BACE1 inhibition minimizes the side-effect of 
presynaptic dysfunction, hence may be a better treatment for AD. Future studies will 
be necessary to examine whether nicotine or α7-nAChR agonist can rescue the 
behavioral deficits seen in BACE1 KOs, and more importantly the combination 
treatment needs to be examined in AD models. Furthermore, studies need to be done 
to determine the optimal dose and treatment duration of nicotine or α7-nAChR 
agonist to avoid addiction during AD treatment. 
 
Section 3 Feasibility of BACE1 inhibition as AD treatment 
Inhibition of BACE1, the major neuronal form of β-secretase, has received 
more and more attention as the treatment of AD. It was initially promising because 
knocking out BACE1 in APP transgenic lines, which normally develop Aβ plaques 
and behavioral deficits essentially, alleviated the AD symptoms (Luo et al., 2003; 
Ohno et al., 2004; Laird et al., 2005). However, recent studies, including mine, 
showed that BACE1 knockouts display specific dysfunctions in synaptic transmission 
and plasticity (Ohno et al., 2004; Laird et al., 2005; Wang et al., 2008), as well as 
behavioral deficits (Harrison et al., 2003; Laird et al., 2005; Savonenko et al., 2008). 




have normal physiological functions, further caution the use of BACE1 inhibition as a 
practical treatment for AD (Wong et al., 2005; Hu et al., 2006; Willem et al., 2006; 
Kim et al., 2007). In order to improve the development of effective therapeutics that 
targets this enzyme, we need to find potential ways to overcome the synaptic deficits 
due to the absence of BACE1 activity or resort to partial inhibition strategies.  
Subsection 1 Partial inhibition or conditional knockdown of BACE1 
It has been shown that Aβ burden is dose-dependent on BACE1 activity. 
Therefore, partial inhibition of BACE1 may be beneficial for AD treatment. To test 
this, Kimura and colleagues crossed BACE1 heterozygous (HT) mice with a line of 
transgenic mice carrying human APP and PS1 with 5 familial AD mutations 
(5XFAD), and found that partial reduction of BACE1 improved remote and recent 
memory and restored CA1 LTP (Kimura et al., 2010). In addition, I have tested 
synaptic function at mossy fiber CA3 synapses using BACE1 HT mice. My 
preliminary data showed that presynaptic function at these synapses in BACE1 HTs is 
recovered compared to KOs as a measure of reduced PPF ratios at 25 and 50 ms ISIs 
(25 ms ISI: HT = 4.3 ± 0.25; KO = 6.1 ± 0.79; 50 ms ISI: HT = 4.0 ± 0.21, n = 12; 
KO = 5.7 ± 0.77, n = 17; Fisher’s PLSD post hoc test: P < 0.01 between HTs and 
KOs; Fig. 2.1A and 5.1A), although the ratios are not restored completely back to the 
levels of WTs (25 ms ISI: WT = 3.3 ± 0.27; HT = 4.3 ± 0.25; 50 ms ISI: WT = 3.4 ± 
0.21, n = 12; HT = 4.0 ± 0.21, n = 12; Fisher’s PLSD post hoc test: P < 0.01 between 
WTs and HTs; Fig. 5.1A). BACE1 HTs display significant mossy fiber LTP 
compared to BACE1 KOs (HT: 128 ± 3% of baseline at 1 hour post-HFS, n = 12 





Figure 5.1. BACE1 HTs display a slight reduction in presynaptic function at 
mossy fiber to CA3 PCs synapses remaining partial mossy fiber LTP. 
A. Slightly larger PPF ratio in BACE1 HTs. The difference between WTs (white 
circles) and HTs (grey circles) are significant at 25 and 50 msec ISIs. *ANOVA: 
P < 0.01; Fisher’s PLSD post hoc test: P < 0.01 between the two genotypes. 
B. BACE1 HTs display partial mossy fiber LTP. Left: Summary graph plotting 
changes in normalized field potential against time. The arrow depicts when HFS 
(100 Hz, 1 sec x 3) was delivered. Right: Superimposed representative field 
potential traces taken from WTs and HTs at times indicated in the left panel. 
KOs; Fig. 2.2A and 5.1B), although the magnitude of the LTP is less than that of 
WTs (WT: 149 ± 3% of baseline at 1 hour post-HFS, n = 12 slices/6 mice; HT: 128 ± 
3%, n = 12 slices/5 mice; t-test: P < 0.01 between WTs and HTs; Fig. 5.1B). These 
data suggest that although the presynaptic release is also impaired in BACE1 HTs, the 
damage is not as severe as that in BACE1 KOs, and mossy fiber LTP is partially 
expressed in BACE1 HTs. Therefore partial inhibition of BACE1 produces less 
synaptic dysfunction at mossy fiber synapses to CA3 pyramidal cells compared to 




Another potential method is knockdown of BACE1. Researchers have 
successfully suppressed BACE1 activity by using RNA interference (RNAi) in vitro 
(Kao et al., 2004; Dong et al., 2006) and in vivo (Laird et al., 2005; Singer et al., 
2005). Lentiviral BACE1 siRNA delivered into the hippocampus has been found to 
effectively reduce Aβ production, neurodegeneration, and behavioral deficits in APP 
transgenic mice (Laird et al., 2005; Singer et al., 2005). Characterizing synaptic 
function in the BACE1 siRNA knockdown models may provide information about 
acute effects of blocking BACE1 function. In addition, siRNA knockdown of BACE1 
in APP transgenic lines will better approximate clinical situations, and hence allow us 
to better estimate the feasibility of developing an effective treatment of AD by 
BACE1 inhibition. 
Subsection 2 BACE1 inhibitors 
Since the identification of BACE1, the development of BACE1 inhibitors has 
been initiated. However, the progress was slow, probably due to the difficulty of 
identifying small molecules that can pass through the blood brain barrier and also 
have high stability and good pharmaceutical properties (Citron, 2004a; Ghosh et al., 
2008a). So far, several BACE1 inhibitors have been discovered, among them only 
CTS-21166 has passed Phase I clinical trials (see review (Ghosh et al., 2008a; Luo 
and Yan, 2010)). Many BACE1 inhibitors have been shown to decrease soluble Aβ 
production, amyloid plaque deposition, as well as improve cognitive function in AD 
animal models (Hussain et al., 2007; Ghosh et al., 2008b; Fukumoto et al., 2010; 
Takahashi et al., 2010; Zhu et al., 2010; Chang et al., 2011). Surprisingly, none of 




cellular mechanism that correlates with cognitive decline. A critical question is 
whether these inhibitors can recover synaptic deficits seen in AD models, or whether 
they may produce additional defects in the normal brain. 
Subsection 3 Transcriptional and miRNA regulation of BACE1regulation 
of BACE1 
There are several reports of transcriptional regulation of BACE1. Nie et al. 
have shown that activation of α4β2 nAChR can decrease BACE1 transcription 
through the ERK1-NFκB pathway in SH-EP1 cell line expressing human APP695 
and human nAChR α4 and β2 subunit (Nie et al., 2011); Wen and colleagues reported 
that overexpression of p25, an activator of cdk5, can increase levels of BACE1 
mRNA and protein likely through interactions of signal transducer and activator of 
transcription (STAT3) with the BACE1 promoter (Wen et al., 2008). In addition, in 
sporadic AD patients’ brains, an increase in BACE1 levels is correlated with a 
decrease in a subset of microRNAs (miRNA), especially the miR-29a/b-1 miRNA 
cluster (Hebert et al., 2008). miRNAs can regulate mRNA translation. Therefore, it is 
possible that an increase in specific miRNA levels can down regulate BACE1 protein 
expression and decrease Aβ burden. These findings provide various ways to regulate 
BACE1 expression. 
Subsection 4 Endogenous BACE1 activity modulators 
Recently, studies have shown that during sporadic AD or in AD animal 
models, the activities of certain endogenous molecules are modified, which 




phosphorylation of the translation initiation factor eIF2α and calpain activity are 
increased in AD, which can lead to an increase in BACE1 activity (O'Connor et al., 
2008; Liang et al., 2010; Nimmrich et al., 2010; Ill-Raga et al., 2011; Takasugi et al., 
2011). On the other hand, conjugated linoleic acid (CLA), acetylcholinesterase 
inhibitor galantamine (Gal), copper chaperone for superoxide dismutase (CCS), 
PPARγ co-activator-1α (PGC-1α), trafficking molecule GGA3, as well as Fbx2-E3 
ligase activity are decreased in AD, which leads to increased BACE1 protein levels 
(Tesco et al., 2007; Sarajarvi et al., 2009; Gong et al., 2010; Gray et al., 2010; Kang 
et al., 2010; Li et al., 2010; Katsouri et al., 2011; Li et al., 2011). So far, only the 
effect of Fbx2 on synaptic plasticity has been tested. Adenoviral-Fbx2 transfection 
significantly improves LTP in the CA1 region of the hippocampus of Tg2576 mice 
without affecting basal synaptic transmission (Gong et al., 2010). Although 
modulating these molecules or signaling pathways can be potential methods to 
control BACE1 activity, further studies need to be done to verify whether synaptic 
function can be improved by manipulating BACE1 modulators. 
Subsection 5 Pharmacological means that increase presynaptic Ca2+ 
signaling 
From my study, I have found that the presynaptic dysfunction in BACE1 KOs 
is likely at the level of presynaptic Ca2+ signaling, therefore, it is possible that 
manipulations that enhance presynaptic Ca2+ may overcome the synaptic deficits 
caused by inhibiting BACE1 activity. This opens up possibilities of using 
pharmacological means to enhance presynaptic Ca2+ signal, which in turn can restore 




development of effective pharmacological means for treating AD by combining 
BACE1 inhibitors with specific agents that can enhance presynaptic Ca2+ signal. 
One possible way is modulating presynaptic Ca2+ permeable α7-nAChRs. My 
study showed that activation of α7-nAChRs, by nicotine or α7-nAChRs agonist, can 
restore PPF ratio and mossy fiber LTP in BACE1 KO mice. The cellular mechanism 
of nicotine-induced rescue is dependent on the recruitment of Ca2+ induced Ca2+ 
release from intracellular Ca2+ stores through ryanodine receptors. These results 
suggest that nicotine or α7-nAChR agonists may be potential pharmacological means 
to circumvent the presynaptic dysfunctions caused by BACE1 inhibition.  
Another candidate is mGluR2 which acts as inhibitory autoreceptor at mossy 
fiber terminals to potently block glutamate release by a mechanism that likely 
includes inhibition of presynaptic voltage-gated Ca2+ channels (Kamiya and Ozawa, 
1999; Pelkey et al., 2006). Therefore, it is possible that by using specific antagonist of 
mGluR2, it would facilitate presynaptic voltage-gated Ca2+ channels and enhance 
presynaptic Ca2+ influx. However, recent study has shown that repetitive stimulation 
can activate mGluR2, which limits the magnitude of frequency facilitation, and 
antagonist of mGluR2 is reported to enhance frequency facilitation during low 
frequency stimulation (Kwon and Castillo, 2008a). Therefore, mGluR2 inhibition 
may not reduce PPF ratio in BACE1 KOs. To verify whether blocking mGluR2 is 
beneficial to presynaptic function recovery, future study should be done to compare 
frequency facilitation in BACE1 KOs with and without mGluR2 antagonist, to see 
whether BACE1 KOs show deficits in frequency facilitation, and whether mGluR2 




A third potential target that is thought to regulate presynaptic release is kainate 
receptor (KAR), which is another ionotropic glutamate receptor aside from NMDAR 
and AMPAR. It has been shown that dentate gyrus granule cells strongly express 
KARs especially in stratum lucidum which is the mossy fiber terminal zone 
suggesting presynaptic location of KARs (Monaghan and Cotman, 1982; Wisden and 
Seeburg, 1993; Darstein et al., 2003). Interestingly, low concentrations of kainate (20-
100 nM), which activate KARs, have been found to enhance synaptic transmission at 
hippocampal mossy fiber synapses (Schmitz et al., 2001; Ji and Staubli, 2002; 
Contractor et al., 2003; Rodriguez-Moreno and Sihra, 2004). This enhancement is 
mediated, at least partially, by increased release probability (Schmitz et al., 2001; Ji 
and Staubli, 2002). Additionally, several studies have suggested that presynaptic 
KARs may facilitate the induction of mossy fiber LTP (Contractor et al., 2001; Lauri 
et al., 2001; Bortolotto et al., 2003; Schmitz et al., 2003). Although the detailed 
mechanism of KAR mediated enhancement of glutamate release is not very clear, 
Kamiya et al. found that increase of presynaptic Ca2+ is likely involved (Kamiya et al., 
2002). These evidences provide possibility that activation of KARs may rescue the 
presynaptic deficits seen in BACE1 KOs. However, contradictory results also exit. 
Kwon and colleagues have evidence suggesting that activation of KARs by 50nM 
kainite does not enhance transmitter release at mossy fiber to CA3 synapses, and 
short-term plasticity at these synapses is KAR independent (Kwon and Castillo, 
2008a). If this is the case, KARs activation may not rescue the presynaptic 
dysfunction in BACE1 KOs; but if future studies show that activation of these 




rescue of presynaptic deficits involve utilizing signaling pathways which are normally 






Comparison of statistical analysis using data from slices or data from animals 
 
Take paired-pulse facilitation (PPF) ratio data from wild type animals as an example: 
 
Statistics using data from slices 
ISI(ms) Ave. PPF ratio SD SEM CV Num. of slices
25 3.392429 0.682648 0.241353 0.201227 8
50 3.452732 0.657079 0.232313 0.190307 8
100 3.122592 0.595195 0.210433 0.190609 8
200 2.185701 0.230974 0.081662 0.105675 8
400 1.708131 0.114219 0.040383 0.066868 8
1000 1.460462 0.113193 0.040020 0.077505 8
2000 1.232870 0.070771 0.025021 0.057404 8
 
Statistics using data from animals 
ISI(ms) Ave. PPF ratio SD SEM CV Num.of animals
25 3.392429 0.355143 0.177571 0.104687 4
50 3.452732 0.417338 0.208669 0.120872 4
100 3.122592 0.424468 0.212234 0.135935 4
200 2.185701 0.198730 0.099365 0.090923 4
400 1.708131 0.051059 0.025530 0.029892 4
1000 1.460462 0.059047 0.029523 0.040430 4
2000 1.232870 0.037512 0.018756 0.030426 4
 
The tables above show that the Coefficient of Variation (CV) of data from slices 
is consistently larger than that from animals, suggesting that the major variability 
tends to come from the difference among the slices not that across the animals. 
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